<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>2
<FILENAME>d828186dex2.htm
<DESCRIPTION>EX-2.01
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.01</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.01 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE
AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated as of </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">November 23, 2014 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">among </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSENSA HOLDING N.V., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BIOMARIN PHARMACEUTICAL INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BIOMARIN FALCONS B.V.
</B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">P<SMALL>AGE</SMALL></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 1</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">D<SMALL>EFINITIONS</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01. <I>&nbsp;&nbsp;Definitions.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02. <I>&nbsp;&nbsp;Other Definitional and Interpretative Provisions</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 2</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">T<SMALL>HE</SMALL> O<SMALL>FFER</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01. <I>&nbsp;&nbsp;The Offer.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02. <I>&nbsp;&nbsp;Company Action.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03. <I>&nbsp;&nbsp;Outstanding Equity Awards.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04. <I>&nbsp;&nbsp;Extraordinary General Meeting.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05. <I>&nbsp;&nbsp;Directors</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06. <I>&nbsp;&nbsp;Further Actions</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07. <I>&nbsp;&nbsp;Reorganization</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08. <I>&nbsp;&nbsp;Certain Adjustments</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09. <I>&nbsp;&nbsp;Withholding</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 3</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01. <I>&nbsp;&nbsp;Corporate Existence and Power.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02. <I>&nbsp;&nbsp;Corporate Authorization.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03. <I>&nbsp;&nbsp;Governmental Authorization</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04. <I>&nbsp;&nbsp;Non-contravention</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05. <I>&nbsp;&nbsp;Capitalization.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06. <I>&nbsp;&nbsp;Subsidiaries.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07. <I>&nbsp;&nbsp;SEC Filings.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08. <I>&nbsp;&nbsp;Financial Statements.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09. <I>&nbsp;&nbsp;Internal Controls.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10. <I>&nbsp;&nbsp;Disclosure Documents.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11. <I>&nbsp;&nbsp;Absence of Certain Changes.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12. <I>&nbsp;&nbsp;No Undisclosed Material Liabilities</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13. <I>&nbsp;&nbsp;Compliance with Laws; Regulatory Matters.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14. <I>&nbsp;&nbsp;Litigation</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15. <I>&nbsp;&nbsp;Properties.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16. <I>&nbsp;&nbsp;Intellectual Property.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17. <I>&nbsp;&nbsp;Taxes</I>.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18. <I>&nbsp;&nbsp;Employee Benefit Plans.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19. <I>&nbsp;&nbsp;Employee and Labor Matters.</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.20. <I>&nbsp;&nbsp;Environmental Matters</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21. <I>&nbsp;&nbsp;Material Contracts</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22. <I>&nbsp;&nbsp;Finders&#146; Fees</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23. <I>&nbsp;&nbsp;Opinion of Financial Advisor</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24. <I>&nbsp;&nbsp;Insurance.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25. <I>&nbsp;&nbsp;Transactions with Affiliates</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.26. <I>&nbsp;&nbsp;Anti-Takeover Measures</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.27. <I>&nbsp;&nbsp;No Other Representations and Warranties</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 4</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> P<SMALL>ARENT</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01. <I>&nbsp;&nbsp;Corporate Existence and Power</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02. <I>&nbsp;&nbsp;Corporate Authorization</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03. <I>&nbsp;&nbsp;Governmental Authorization</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04. <I>&nbsp;&nbsp;Non-contravention</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05. <I>&nbsp;&nbsp;Disclosure Documents.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06. <I>&nbsp;&nbsp;Finders&#146; Fees</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07. <I>&nbsp;&nbsp;Financing</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.08. <I>&nbsp;&nbsp;Litigation</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.09. <I>&nbsp;&nbsp;Ownership of Shares; Investment.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10. <I>&nbsp;&nbsp;Absence of Certain Agreements</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11. <I>&nbsp;&nbsp;Management Agreements</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12. <I>&nbsp;&nbsp;No Other Representations and Warranties.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 5</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01. <I>&nbsp;&nbsp;Conduct of the Company</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02. <I>&nbsp;&nbsp;Access to Information</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03. <I>&nbsp;&nbsp;No Solicitation; Other Offers.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04. <I>&nbsp;&nbsp;Compensation Arrangements.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05. <I>&nbsp;&nbsp;Anti-Takeover Measures</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06. <I>&nbsp;&nbsp;Innovation Box</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 6</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> P<SMALL>ARENT</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01. <I>&nbsp;&nbsp;Conduct of Parent</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02. <I>&nbsp;&nbsp;Obligations of Buyer</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03. <I>&nbsp;&nbsp;Director and Officer Liability</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.04. <I>&nbsp;&nbsp;Employee Matters.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.05. <I>&nbsp;&nbsp;CVRs</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 7</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> P<SMALL>ARENT</SMALL> <SMALL>AND</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMPANY<B></B></SMALL><B></B></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B></B><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL></SMALL><SMALL><B></B></SMALL><B>&nbsp;&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01. <I>&nbsp;&nbsp;Regulatory Undertakings.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02. <I>&nbsp;&nbsp;Certain Filings</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03. <I>&nbsp;&nbsp;Further Assurances</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.04. <I>&nbsp;&nbsp;Public Announcements</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.05. <I>&nbsp;&nbsp;Notices of Certain Events</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.06. <I>&nbsp;&nbsp;Litigation and Proceedings</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 8 .</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">T<SMALL>ERMINATION</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01. <I>&nbsp;&nbsp;Termination</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02. <I>&nbsp;&nbsp;Effect of Termination</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>ARTICLE 9</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center">M<SMALL>ISCELLANEOUS</SMALL></TD>
<TD VALIGN="top"><SMALL></SMALL>&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.01. <I>&nbsp;&nbsp;Notices</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02. <I>&nbsp;&nbsp;Survival of Representations and Warranties</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03. <I>&nbsp;&nbsp;Amendments and Waivers.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.04. <I>&nbsp;&nbsp;Expenses.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.05. <I>&nbsp;&nbsp;Equity Investment.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06. <I>&nbsp;&nbsp;Disclosure Schedule and SEC Document References.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.07. <I>&nbsp;&nbsp;Binding Effect; Benefit; Assignment.</I></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.08. <I>&nbsp;&nbsp;Governing Law</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.09. <I>&nbsp;&nbsp;Jurisdiction</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10. <I>&nbsp;&nbsp;WAIVER OF JURY TRIAL</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11. <I>&nbsp;&nbsp;Counterparts; Effectiveness</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12. <I>&nbsp;&nbsp;Entire Agreement</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13. <I>&nbsp;&nbsp;Severability</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14. <I>&nbsp;&nbsp;Specific Performance</I>.</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex I &#150; Offer Conditions</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex II &#150; Form of CVR Agreement</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This PURCHASE AGREEMENT (this &#147;<B>Agreement</B>&#148;) dated as of November&nbsp;23, 2014, among Prosensa Holding N.V., a public limited
liability company (<I>naamloze vennootschap</I>) organized under the laws of The Netherlands (the &#147;<B>Company</B>&#148;), BioMarin Pharmaceutical Inc., a Delaware corporation (&#147;<B>Parent</B>&#148;), and BioMarin Falcons B.V., a private
company with limited liability (<I>besloten vennootschap</I>) organized under the laws of The Netherlands and a wholly owned indirect subsidiary of Parent (&#147;<B>Buyer</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>W I T N E S S E T H : </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the supervisory board of directors of the Company (the &#147;<B>Supervisory Board</B>&#148;) and the managing board of directors of
the Company (the &#147;<B>Managing Board</B>&#148; and, together with the Supervisory Board, the &#147;<B>Boards</B>&#148;) have determined that the acquisition of the Company by Buyer on the terms and subject to the conditions set forth herein is
fair to, and in the best interests of, the Company&#146;s shareholders and other stakeholders, its Subsidiaries and the enterprises carried on by the Company and its Subsidiaries and have approved the acquisition of the Company by Parent on the
terms and subject to the conditions set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the respective boards of directors of Parent and Buyer have
approved the acquisition of the Company by Parent on the terms and subject to the conditions set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on the
terms and subject to the conditions set forth herein, Parent will cause Buyer to commence a tender offer (as it may be amended from time to time as permitted by this Agreement, the &#147;<B>Offer</B>&#148;) to purchase any and all of the outstanding
ordinary shares, par value &#128;0.01&nbsp;per share of the Company (collectively, the &#147;<B>Shares</B>&#148;) in exchange for (i)&nbsp;$17.75 per Share, in cash, without interest (the &#147;<B>Cash Consideration</B>&#148;) and (ii)&nbsp;one
contingent value right (a &#147;<B>CVR</B>&#148;), which shall represent the right to receive the Milestone Payments (as defined in the Contingent Value Rights Agreement in the form attached hereto as Annex II) (the
&#147;<B>CVR&nbsp;Agreement</B>&#148;) to be entered into between Parent and a rights agent selected by Parent with the Company&#146;s prior approval (the &#147;<B>Rights</B>&nbsp;<B>Agent</B>&#148;), if any, at the times provided for in the CVR
Agreement, per Share, without interest (the Cash Consideration together with one CVR, the &#147;<B>Offer Consideration</B>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and inducement to the willingness of Parent and
Buyer to enter into this Agreement, the Company&#146;s directors and executive officers and certain shareholders of the Company are entering into tender agreements with Parent and Buyer dated as of the date hereof (the &#147;<B>Tender</B>
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>Agreements</B>&#148;), pursuant to which, among other things, such shareholders are agreeing to tender their respective Shares in the Offer and vote at the EGM, upon the terms and subject to
the conditions set forth therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and
agreements contained herein, the parties hereto agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 1</U> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D<SMALL>EFINITIONS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01. <I>Definitions</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) As used herein, the following terms have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Acquisition Proposal</B>&#148; means, other than the transactions contemplated by this Agreement between Parent, Buyer and the
Company, any offer or proposal (whether or not in writing) made by a Third Party or group (as defined in Section&nbsp;13(d) of the 1934 Act) of Third Parties relating to (i)&nbsp;any acquisition, transfer, purchase or disposition, direct or
indirect, of 20% or more of the consolidated assets of the Company and its Subsidiaries, taken as a whole, or beneficial ownership of 20% or more of any class of equity or voting securities of the Company or any of its Subsidiaries whose assets,
individually or in the aggregate, constitute 20% or more of the consolidated assets of the Company, (ii)&nbsp;any tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in such Third Party&#146;s
beneficially owning 20% or more of any class of equity or voting securities of the Company or any of its Subsidiaries whose assets, individually or in the aggregate, constitute 20% or more of the consolidated assets of the Company or (iii)&nbsp;a
merger, consolidation, share exchange, business combination, sale of substantially all the assets, reorganization, recapitalization, liquidation, dissolution or other similar transaction involving the Company or any of its Subsidiaries whose assets,
individually or in the aggregate, constitute 20% or more of the consolidated assets of the Company.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Action</B>&#148; means any litigation, action, claim, suit, hearing, arbitration, mediation, interference, cancellation,
opposition, reexamination, or other proceeding (public or private) by or before, or otherwise involving, any Governmental Authority.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or
under common control with such Person. For purposes of this definition, the term &#147;control&#148; (including the correlative terms &#147;controlling&#148;, &#147;controlled by&#148; and &#147;under common control with&#148;) means the possession,
directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Applicable Law</B>&#148; means, with respect to any Person, any transnational,
domestic or foreign federal, state or local law, code, rule, regulation, order, injunction, judgment, bylaw, ordinance, decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority that is binding
upon or applicable to such Person, as amended unless expressly specified otherwise.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Business Day</B>&#148; means a
day, other than Saturday, Sunday or other day on which commercial banks in Amsterdam, The Netherlands or New York, New York, United States are authorized or required by Applicable Law to close.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Code</B>&#148; means the United States Internal Revenue Code of 1986.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company Balance Sheet</B>&#148; means the consolidated balance sheet of the Company as of December&nbsp;31, 2013 and the
footnotes thereto set forth in the Company 20-F.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company Balance Sheet Date</B>&#148; means December&nbsp;31,
2013.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company Disclosure Schedule</B>&#148; means the disclosure schedule dated the date hereof regarding this
Agreement that has been provided by the Company to Parent and Buyer.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material Adverse Effect</B>&#148; means any
change, event, occurrence or effect (&#147;<B>Effects</B>&#148;) that, individually or in the aggregate, (i)&nbsp;has or would reasonably be expected to have a material adverse effect on the financial condition, business or results of operations of
the Company and its Subsidiaries, taken as a whole, or (ii)&nbsp;prevents or materially delays the ability of the Company to consummate the Offer; <I><U>provided</U></I>, <I><U>however</U></I>, that, none of the following Effects shall be taken into
account in determining whether there has been or would reasonably be expected to be a Company Material Adverse Effect: (A)&nbsp;changes in IFRS, (B)&nbsp;changes in the financial or securities markets or general economic or political conditions in
The Netherlands, the United States or any other country or region in which the Company and its Subsidiaries operate, (C)&nbsp;changes (including changes of Applicable Law or interpretations thereof) or conditions generally affecting the industry in
which the Company and its Subsidiaries operate, (D)&nbsp;acts of war, sabotage or terrorism or natural disasters, (E)&nbsp;any Effects resulting from or arising out of the execution and performance of this Agreement or the announcement or the
anticipated consummation of the transactions contemplated by this Agreement or the identity of or any facts or circumstances relating to Parent, including the impact of any of the foregoing on the relationships, contractual or otherwise, of the
Company and any of its Subsidiaries with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employees, Governmental Authorities or any other Persons and any shareholder or derivative litigation relating to the execution and performance of this Agreement or the announcement or the
anticipated consummation of the transactions contemplated by this Agreement, other than for purposes of Sections 3.03 and 3.04 or clause (D)&nbsp;of Part 2 of Annex I insofar as it relates to Sections 3.03 and 3.04, (F)&nbsp;any determination by, or
delay of a determination by, the FDA, the EMA or any other Governmental Authority, or any panel or advisory body empowered or appointed thereby, or any indication that any such entity, panel or body will make any determination or delay in making any
determination, with respect to any product or product candidate of the Company or any of its competitors, (G)&nbsp;the results of any pre-clinical or clinical testing sponsored by the Company, any of its competitors or any of their respective
collaboration partners, (H)&nbsp;increased incidence or severity of any previously identified side effects, adverse events or safety observations, or reports of new side effects, adverse events or safety observations, with respect to any products or
product candidates of the Company or any of its competitors, (I)&nbsp;any recommendations, statements or other pronouncements published or proposed by professional medical organizations or the FDA, the EMA any other Governmental Authority, or any
panel or advisory body empowered or appointed thereby, relating to products or product candidates of the Company or any of its competitors, (J)&nbsp;any change or prospective change in reimbursement or payor rules or policies applicable to products
or product candidates of the Company or any of its competitors, (K)&nbsp;any failure in and of itself by the Company or any of its Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance
for any period (<I><U>provided</U></I> that the underlying facts and circumstances giving rise to such failures, unless otherwise excluded by this definition, may be deemed to constitute, and may be taken into account in determining whether there
has been a Company Material Adverse Effect), (L)&nbsp;any action taken (or omitted to be taken) at the request of Parent or Buyer, (M)&nbsp;any action taken by the Company and/or its Subsidiaries that is required or expressly contemplated by this
Agreement, including any actions required under this Agreement to obtain any approval or authorization under applicable antitrust or competition laws for the consummation of the Offer, or (N)&nbsp;a change in the price and/or trading volume of the
Shares on the NASDAQ or any other market in which such securities are quoted for purchase and sale (<I><U>provided</U></I> that the underlying facts and circumstances giving rise to such changes, unless otherwise excluded by this definition, may be
deemed to constitute, and may be taken into account in determining whether there has been a Company Material Adverse Effect); <I><U>provided</U></I>, <I><U>however</U></I>, that in the case of the exceptions in clauses (A)&nbsp;through (D), to the
extent such Effect disproportionately impacts the Company and its Subsidiaries, taken as a whole, as compared to other Persons engaged in the business in which the Company and its Subsidiaries engage, the incremental disproportionate impact may be
taken into account in determining whether there has been a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company Plan&#148; </B>means each employee benefit plan, and any other collective
or individual plan, policy, program, practice or agreement (whether qualified or nonqualified, funded or unfunded, foreign or domestic, currently effective or terminated) providing compensation or other benefits to any current or former Company
Service Provider (or to any dependent or beneficiary thereof) which are maintained, sponsored or contributed to by the Company or any of its Subsidiaries, or under which the Company or any of its Subsidiaries has any liability or obligations,
including all incentive, bonus, pension, profit sharing, retirement, deferred compensation, severance, paid garden leave, pay in lieu of notice of termination, seniority premium, vacation, paid time off, holiday, relocation, repatriation, medical,
disability, death benefit, workers&#146; compensation, fringe benefit, Tax gross-up, Tax equalization, change in control, stock purchase, stock option, stock appreciation, phantom stock, restricted stock or other stock-based compensation plans,
policies, programs, practices, agreements or arrangements, other than any such plan or agreement that (i)&nbsp;(A)&nbsp;is statutorily mandated or (B)&nbsp;is implemented, administered or operated by any Governmental Authority and (ii)&nbsp;with
respect to which the Company or any of its Subsidiaries does not contribute more than the minimum amounts required by Applicable Law. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company Registered Intellectual Property</B>&#148; means Registered Intellectual Property (i)&nbsp;owned or purportedly owned,
solely or jointly, by the Company or any of its Subsidiaries, or (ii)&nbsp;exclusively licensed (for any field, product use or geography) to the Company or any of its Subsidiaries and which the Company or any of its Subsidiaries controls the
prosecution of before applicable Governmental Authorities.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company Service Provider</B>&#148; means an employee,
individual consultant, individual independent contractor, individual self-employed contractor, leased employee or director of the Company or any of its Subsidiaries. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Company 20-F</B>&#148; means the Company&#146;s annual report on Form 20-F for the fiscal year ended December&nbsp;31,
2013.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Compensation Arrangement Approvals</B>&#148; means the Compensation Committee&#146;s approval of each
Company Plan pursuant to which consideration is payable to any director, officer or employee as an &#147;employment compensation, severance or other employee benefit arrangement&#148; within the meaning of Rule 14d-10(d)(2) under the 1934 Act and
all other actions necessary or advisable to satisfy the requirements of the non-exclusive safe harbor with respect to such Company Plan in accordance with Rule 14d-10(d)(2) under the 1934 Act.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Compensation Committee</B>&#148; means the Compensation Committee of the Boards.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Copyrights</B>&#148; means all copyrights, whether in published or unpublished
works, databases, data collections and rights therein, mask work rights, software, web site content; rights to compilations, collective works and derivative works of any of the foregoing and moral rights in any of the foregoing; registrations and
applications for registration for any of the foregoing and any renewals or extensions thereof.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Domain
Names</B>&#148; means internet domain names registered with or assigned by any domain name registrar, domain name registry or other domain name registration authority as part of an electronic address on the Internet.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>&#147;<I></I><B>Dutch Civil Code</B><I></I>&#148; means the Dutch Civil Code (<I>Burgerlijk Wetboek</I>).<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>&#147;<I></I><B>Dutch Merger Code</B><I></I>&#148; means the Merger Code 2000 (<I>SER-besluit Fusiegedragsregels 2000</I>).<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>EMA</B>&#148; means the European Medicines Agency.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Environmental Laws</B>&#148; means any and all Applicable Laws relating to pollution or protection of human health (to the
extent related to exposure to Hazardous Substances) or the environment.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>FDA</B>&#148; means the United States Food
and Drug Administration.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Governmental Authority</B>&#148; means any transnational, domestic or foreign federal,
state or local governmental, regulatory or administrative authority, department, court, agency or official, including any political subdivision thereof.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Hazardous Substance</B>&#148; means (i)&nbsp;any material, substance or waste (whether liquid, gaseous or solid) that
(A)&nbsp;requires investigation, removal, remediation, reporting or other response action under any Environmental Law, or is listed, classified or regulated as a &#147;hazardous waste&#148; or &#147;hazardous substance&#148; (or other similar term)
pursuant to any applicable Environmental Law or (B)&nbsp;is regulated under applicable Environmental Laws as being, toxic, explosive, corrosive, flammable, infectious, radioactive, carcinogenic, mutagenic or otherwise hazardous; and (ii)&nbsp;any
petroleum product or by-product, petroleum-derived substances wastes or breakdown products, friable asbestos, lead-based paint or polychlorinated biphenyls.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>HSR Act</B>&#148; means the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>IFRS</B>&#148; means International Financial Reporting Standards, as in effect from time to time and as issued by the
International Accounting Standards Board.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means Copyrights, Domain Names, Patents, Trademarks,
Know-How, and any other similar type of proprietary intellectual property rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intervening Event</B>&#148; has the meaning
set forth on Schedule 1.01(a) of the Company Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Key Product</B>&#148; means each of the following Company
product candidates: drisapersen (f/k/a PRO051), PRO044, PRO045, PRO053, PRO052, PRO055, and PROSPECT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Know-How</B>&#148; means
unpublished inventions (whether patentable or not), industrial designs, discoveries, invention disclosures, improvements, ideas, designs, models, formulae, recipes, patterns, compilations, data collections, diagrams, drawings, blueprints, mask
works, devices, methods, techniques, processes, know-how, instructions, configurations, prototypes, samples, specifications, technology, trade secrets, confidential information, proprietary information, customer lists, source code and technical
information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>knowledge</B>&#148; means (i)&nbsp;(A)&nbsp;with respect to the Company, the actual knowledge of the individuals
listed on Section&nbsp;1.01(b) of the Company Disclosure Schedule and (B)&nbsp;with respect to Parent, the actual knowledge of the executive officers of Parent, and (ii)&nbsp;any fact or matter which any such Person in clause (i)&nbsp;of this
definition would reasonably be expected to discover or otherwise become aware in the course of the conduct of his or her duties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; means, with respect to any property or asset, any mortgage, lien, pledge, charge, security interest, encumbrance or
other similar adverse claim of any kind in respect of such property or asset. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>NASDAQ</B>&#148; means The NASDAQ Stock Market
LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>1933 Act</B>&#148; means the United States Securities Act of 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>1934 Act</B>&#148; means the United States Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parent Material Adverse Effect</B>&#148; means any Effect, that, individually or in the aggregate, would reasonably be expected to
prevent or materially delay the ability of Parent or Buyer to consummate the Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Patents</B>&#148; means (i)&nbsp;all
national, regional and international patents and patent applications, including provisional patent applications, (ii)&nbsp;all patent applications filed either from such patents, patent applications or provisional applications or from an application
claiming priority from any of the foregoing, including divisionals, continuations, continuations-in-part, provisionals, converted provisionals and continued prosecution applications, (iii)&nbsp;any and all patents that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have issued or in the future issue from the foregoing patent applications ((i) and (ii)), including utility models, petty patents, innovation patents and design patents and certificates of
invention, and (iv)&nbsp;any and all extensions or restorations by existing or future extension or restoration mechanisms, including revalidations, reissues, re-examinations and extensions (including any supplementary protection certificates and the
like) of the foregoing patents or patent applications ((i), (ii)&nbsp;and (iii)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means an individual,
corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registered Intellectual Property</B>&#148; means all Intellectual Property that is the subject of an application for registration or
registration issued, filed with, or recorded by any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the United States Securities and
Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SER</B>&#148; means the Social and Economic Council of the Netherlands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; means, with respect to any Person, any entity of which (i)&nbsp;such Person or any other Subsidiary of such
Person is a general partner (in the case of a partnership) or managing member (in the case of a limited liability company), (ii)&nbsp;voting power to elect a majority of the board of directors, board of managers or others performing similar
functions with respect to such organization is held by such Person or by any one or more of such Person&#146;s Subsidiaries, (iii)&nbsp;at least 50% of any class of capital stock or of the outstanding equity interests are beneficially owned by such
Person, or (iv)&nbsp;any Person that would otherwise be deemed a &#147;subsidiary&#148; under Rule 12b-2 promulgated under the 1934 Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; or &#147;<B>Taxes</B>&#148; means all forms of taxes and similar levies, duties, charges, surcharges, imposts and
withholdings of any nature whatsoever, including income tax, corporation tax, corporation profits tax, advance corporation tax, capital gains tax, capital acquisitions tax, compensation, unemployment, transfer, occupation, customs duties, severance,
payroll, ad valorem, residential property tax, wealth tax, value added tax, withholding tax, customs and other import and export duties, excise duties, stamp duty, capital duty, social insurance, social welfare or other similar contributions and
other amounts corresponding thereto imposed by any Governmental Authority (a &#147;<B>Taxing Authority</B>&#148;) and all penalties, charges, costs and interest relating thereto and shall include any transferee or successor liability in respect in
any and all of the above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; means any report, return, document, declaration or other information or filing
required to be supplied to any Taxing Authority with respect </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to Taxes, including information returns, any documents with respect to or accompanying payments of estimated Taxes, or with respect to or accompanying requests for the extension of time in which
to file any such report, return, document, declaration or other information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Third Party</B>&#148; means any Person, including
as defined in Section&nbsp;13(d) of the 1934 Act, other than Parent or any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trademark</B>&#148; means any
trademark, trade dress, brand mark, service mark, trade name, brand name, product configuration, logo or business symbol, or other source identifier, whether or not registered, and all goodwill associated therewith and symbolized thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of the following terms is defined in the Section set forth opposite such term: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:24.85pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Section</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acceptable Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;5.03(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adverse Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.03(d)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alternative Acquisition Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anti-Takeover Measure</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.26</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Division</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 7.01(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Approval of the Boards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.06</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset Sale</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.04(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset Sale Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;2.04(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Boards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buyer Directors</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.05</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(d)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(d)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Documents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.10(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Option</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Permits</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.13(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.02(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Restricted Share</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.03(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.07(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.05(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subsidiary Securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.06(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.02</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuing Employee</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 6.04(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion Shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 9.05(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.04(a)(iii)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:24.85pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Section</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVR</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVR Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D&amp;O Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;6.03(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EGM</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.04(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EGM Materials</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;2.04(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employment Practices</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.19(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">End Date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;8.01(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.02(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise Period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.03(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expiration Time</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.08(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FTC</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 7.01(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GLP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.12</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Person</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 6.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Expiration Time</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Independent Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.04(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Innovation Box</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.06</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intervening Event</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.03(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intervening Event Notice Period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.03(f)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;3.15(a)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing Board</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contract</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.21</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Minimum Condition</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Annex I</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Note Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;2.04(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Note Payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.04(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 9.01</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offer Commencement Date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offer Conditions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offer Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offer Documents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(e)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred Shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 3.05(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pre-Launch Condition</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Promissory Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 9.05(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reorganization</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.07</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedule TO</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(e)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedule 14D-9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.02(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Step Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.04(a)(iv)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shareholder Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.04(f)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Offering Period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 2.01(c)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:24.85pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Section</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Superior Proposal</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;5.03(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Superior Proposal Notice Period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 5.03(e)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Board</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tender Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;9.04(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section&nbsp;3.01(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Section 9.05</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02. <I>Other Definitional and Interpretative Provisions.</I> The words &#147;hereof&#148;,
&#147;herein&#148; and &#147;hereunder&#148; and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein are included for convenience of
reference only and shall be ignored in the construction or interpretation hereof. References to Articles, Sections, Exhibits, Annexes and Schedules are to Articles, Sections, Exhibits, Annexes and Schedules of this Agreement unless otherwise
specified. All Exhibits, Annexes and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit, Annex or Schedule but not
otherwise defined therein, shall have the meaning as defined in this Agreement. Any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words &#147;include&#148;, &#147;includes&#148;
or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;, whether or not they are in fact followed by those words or words of like import. &#147;Writing&#148;,
&#147;written&#148; and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References to any statute shall be deemed to refer to such statute as amended from time to time
and to any rules or regulations promulgated thereunder. References to any agreement or contract are to that agreement or contract as amended, modified or supplemented from time to time in accordance with the terms hereof and thereof. References to
any Person include the successors and permitted assigns of that Person. References from or through any date mean, unless otherwise specified, from and including or through and including, respectively. References to &#147;law&#148;, &#147;laws&#148;
or to a particular statute or law shall be deemed also to include any Applicable Law. References to &#147;$&#148; refer to U.S. dollars and references to &#147;&#128;&#148; refer to Euros. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 2 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">T<SMALL>HE</SMALL> O<SMALL>FFER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01. <I>The Offer</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Provided that nothing shall have occurred that would give rise to a right to terminate this Agreement pursuant to Article 8, as promptly as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
</B>practicable after the date hereof, but in no event later than the later of (A)&nbsp;fifteen Business Days following the date of this Agreement and (B)&nbsp;five Business Days following the
date of satisfaction or waiver by Buyer and the Company of the condition set forth under Part 1 of Annex I hereto (the &#147;<B>Pre-Launch Condition</B>&#148;), Buyer shall commence (within the meaning of Rule 14d-2 under the 1934&nbsp;Act) the
Offer. The Pre-Launch Condition is for the benefit of both Buyer and the Company and may be waived only by the Company and Buyer jointly (either in whole or in part) by written agreement. No party may invoke the Pre-Launch Condition if the
non-satisfaction of such condition is caused by a breach of that party of any of its obligations under this Agreement. The obligations of Buyer to, and of Parent to cause Buyer to, accept for payment, and pay for, any Shares tendered pursuant to the
Offer shall be subject to the satisfaction or waiver (to the extent permitted under this Agreement) of the conditions set forth in Part 2 of Annex I hereto (the &#147;<B>Offer Conditions</B>&#148;). The date on which Buyer commences the Offer is
referred to as the &#147;<B>Offer Commencement Date</B>&#148;.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(b) Buyer expressly reserves the right at any time to, its
sole discretion, waive, in whole or in part, any of the Offer Conditions and to make any change in the terms of or conditions to the Offer; <I>provided</I> that, without the prior written consent of the Company, Buyer shall not:<I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) waive or change the Minimum Condition (as defined in Annex I); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) decrease the Offer Consideration; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) change the form of consideration to be paid in the Offer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) decrease the number of Shares sought in the Offer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) extend or otherwise change the Expiration Time except as otherwise provided in this Agreement; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) impose additional Offer Conditions or otherwise amend, modify or supplement any of the Offer Conditions or terms of the
Offer in a manner adverse to the holders of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(c) Unless extended as provided in this Agreement, the Offer shall expire
at 12:00&nbsp;midnight (New York City time) on the date that is twenty Business Days (calculated as set forth in Rule 14d-1(g)(3) under the 1934 Act) after the Offer Commencement Date (such time, the &#147;<B>Initial Expiration Time</B>&#148; or
such time and any subsequent time to which the expiration of the Offer is extended in accordance with the terms of this Agreement, the &#147;<B>Expiration Time</B>&#148;). Subject to the provisions of Article 8, if any of the Offer Conditions is <B>
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
</B>not satisfied or waived at the Initial Expiration Time or at any other Expiration Time of the Offer, Buyer shall extend the Offer (the length of such extension period to be determined by
Parent or Buyer, subject to clauses (i)-(iii)&nbsp;below) from time to time until such Offer Condition or Offer Conditions are satisfied or waived; <B></B><I>provided</I><B></B> that (i)&nbsp;Buyer shall not be required to extend the Offer beyond
the End Date, (ii)&nbsp;no such individual extension of the Offer shall be for a period of more than ten Business Days, and (iii)&nbsp;Buyer shall not be required to extend the Offer at any time that Parent or Buyer is permitted to terminate this
Agreement. Buyer shall extend the Offer for any period required by any rule, regulation, interpretation or position of the SEC, the staff thereof or the NASDAQ applicable to the Offer or as may be required by any other Governmental Authority;
<B></B><I>provided</I><B></B>, that Buyer shall not be required to extend the Offer to a date later than the End Date. Following expiration of the Offer, Buyer shall (and the Offer Documents shall so indicate) provide a subsequent offering period
(&#147;<B>Subsequent Offering Period</B>&#148;) in accordance with Rule 14d-11 of the 1934 Act of not less than five nor more than twenty Business Days (for this purpose calculated in accordance with Rule 14d-1(g)(3) under the 1934&nbsp;Act). The
Offer may not be terminated prior to the Expiration Time (as the same may be extended pursuant to this Section&nbsp;2.01) unless this Agreement is validly terminated pursuant to Section 8.01. If this Agreement is validly terminated pursuant to
Section&nbsp;8.01, Buyer shall promptly (and in any event within 24 hours following such termination) terminate the Offer and not acquire any Shares pursuant thereto. If the Offer is terminated by Buyer prior to the acceptance for payment and
payment for Shares tendered in the Offer, Buyer shall promptly return, and shall cause any depositary acting on behalf of Buyer to return, in accordance with Applicable Law, all tendered Shares to the registered holders thereof. Nothing in this
Section 2.01(c) shall affect any termination rights under Article&nbsp;8.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(d) Subject to the terms and conditions set forth
in this Agreement and to the satisfaction or waiver of the Offer Conditions, Buyer shall, and Parent shall cause it to, accept for payment and pay for, as promptly as practicable after the expiration of the Offer, all Shares (i)&nbsp;validly
tendered and not withdrawn pursuant to the Offer and (ii)&nbsp;validly tendered in the Subsequent Offering Period (the date on which Shares are first accepted for payment and paid for under the Offer, the &#147;<B>Closing Date</B>&#148; and the
acceptance for payment and payment for Shares on the Closing Date, the &#147;<B>Closing</B>&#148;). The Cash Consideration payable in respect of each Share pursuant to the preceding sentence shall be paid net of any applicable tax withholding with
respect to the Offer Consideration pursuant to Section 2.09 to the seller in cash, without interest, on the terms and subject to the conditions of this Agreement.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(e) As soon as practicable on the Offer Commencement Date, Parent and Buyer shall (i)&nbsp;file with the SEC a Tender Offer Statement
on Schedule TO with respect to the Offer (together with all amendments and supplements thereto and including exhibits thereto, the &#147;<B>Schedule TO</B>&#148;) that shall include the <B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
</B>summary term sheet required thereby and, as exhibits, the Offer to Purchase and a form of letter of transmittal and summary advertisement (collectively, together with any amendments or
supplements thereto, the &#147;<B>Offer Documents</B>&#148;) and (ii)&nbsp;cause the Offer Documents to be disseminated to holders of Shares to the extent required by applicable United States federal securities laws and any other Applicable Law. The
Company shall promptly furnish to Parent and Buyer all information concerning the Company required by the 1934 Act to be set forth in the Offer Documents. Each of Parent, Buyer and the Company agrees promptly to correct any information provided by
it for use in the Schedule TO and the Offer Documents if and to the extent that such information shall have become (or shall have become known to be) false or misleading in any material respect. Parent and Buyer shall use their reasonable best
efforts to cause the Schedule TO as so corrected to be filed with the SEC and the Offer Documents as so corrected to be disseminated to holders of Shares, in each case to the extent required by applicable United States federal securities laws and
any other Applicable Law. The Company and its counsel shall be given a reasonable opportunity to review and comment on the Schedule TO and the Offer Documents each time before any such document is filed with the SEC, and Parent and Buyer shall give
reasonable and good faith consideration to any comments made by the Company and its counsel. Parent and Buyer shall provide the Company and its counsel with (i)&nbsp;any comments or other communications, whether written or oral, that Parent, Buyer
or their counsel may receive from time to time from the SEC or its staff or other Governmental Authorities with respect to the Schedule TO or the Offer Documents promptly after receipt of those comments or other communications and (ii)&nbsp;a
reasonable opportunity to participate in the response of Parent and Buyer to those comments and to provide comments on that response (to which reasonable and good faith consideration shall be given), including by participating with Parent and Buyer
or their counsel in any discussions or meetings with the SEC or other Governmental Authorities to the extent such participation is permitted by the SEC or other Governmental Authorities.<B> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.02. <I>Company Action</I>. <I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company hereby approves and consents to the Offer and the transactions contemplated by this Agreement (other than approval of
Independent Directors required by Section&nbsp;2.07) and the Tender Agreements. The Company represents that it has been advised that all of the members of the Boards who own Shares intend to tender such shares pursuant to the Offer. The Company
shall promptly (and in any event within three Business Days prior to the Offer Commencement Date) furnish Parent with (i)&nbsp;a list of its shareholders and mailing labels containing the names and addresses of its record holders of Shares,
(ii)&nbsp;any available listing and computer file containing the names and addresses of all record holders of Shares and lists of securities positions of Shares held in stock depositories, and (iii)&nbsp;copies of all lists of shareholders, security
position listings, computer files in the Company&#146;s possession or control regarding the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
beneficial owners of Shares, in each case, true and correct as of the most recent practicable date, and shall provide to Parent such additional information (including updated lists of
shareholders, mailing labels and lists of securities positions) and such other assistance as Parent may reasonably request in connection with the Offer. Notwithstanding the foregoing, the Company shall not be required to provide such information to
the extent the Company is prohibited from providing such information by the terms of its Articles of Association and/or by Applicable Law. In the event that the Company is so prohibited from providing such information, it shall (i)&nbsp;request
permission from the applicable shareholders to provide such information to Parent and Buyer and/or (ii)&nbsp;if the information requested is not received at least three Business Days prior to the Offer Commencement Date, the Company shall deliver to
such shareholders all information that would otherwise be required to be provided by Buyer and Parent to such shareholders of the Company in connection with the Offer, and, notwithstanding this Article 2, Buyer and Parent shall not have any
obligation to deliver such information to such shareholders under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) As soon as practicable after the Offer
Commencement Date (and in any event within ten Business Days of the date the Offer Documents are filed with the SEC), the Company shall file with the SEC and disseminate to holders of Shares, in each case as and to the extent required by applicable
United States federal securities laws and any other Applicable Law, a Solicitation/Recommendation Statement on Schedule 14D-9 (together with any amendments or supplements thereto, the &#147;<B>Schedule 14D-9</B>&#148;) that, subject to
Section&nbsp;5.03(e) and Section 5.03(f), shall reflect the Company Recommendation. Parent and Buyer shall promptly furnish to the Company all information concerning Parent and Buyer required by the 1934 Act to be set forth in the Schedule 14D-9.
Each of the Company, Parent and Buyer agrees promptly to correct any information provided by it for use in the Schedule 14D-9 if and to the extent that it shall have become (or shall have become known to be) false or misleading in any material
respect. The Company shall use reasonable best efforts to cause the Schedule 14D-9 as so corrected to be filed with the SEC and to be disseminated to holders of Shares, in each case to the extent required by applicable United States federal
securities laws and any other Applicable Law. Parent, Buyer and their counsel shall be given a reasonable opportunity to review and comment on the Schedule 14D-9 each time before it is filed with the SEC, and the Company shall give reasonable and
good faith consideration to any comments made by Parent, Buyer and their counsel. The Company shall provide Parent, Buyer and their counsel with (i)&nbsp;any comments or other communications, whether written or oral, that the Company or its counsel
may receive from time to time from the SEC or its staff or other Governmental Authorities with respect to the Schedule 14D-9 promptly after receipt of those comments or other communications and (ii)&nbsp;a reasonable opportunity to participate in
the Company&#146;s response to those comments and to provide comments on that response (to which <B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
</B>reasonable and good faith consideration shall be given), including by participating with the Company or its counsel in any discussions or meetings with the SEC or other Governmental
Authorities to the extent such participation is permitted by the SEC or other Governmental Authorities.<B> </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.03.
<I>Outstanding Equity Awards</I>. <I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) Each option to purchase Shares granted under any Company Plan, whether vested or
unvested, that is outstanding as of immediately prior to the Closing (each, a &#147;<B>Company Option</B>&#148;) and that has an exercise price per share that is less than or equal to the Cash Consideration shall become fully vested and exercisable
as of immediately prior to the Closing and, at the Closing, shall be cancelled in exchange for the right to receive (i)&nbsp;a cash payment from Parent at the Closing to the holder thereof equal to the product of (A)&nbsp;the excess of the Cash
Consideration over the applicable per share exercise price of such Company Option multiplied by (B)&nbsp;the number of Shares subject to such Company Option and (ii)&nbsp;one CVR for each Share subject to such Company Option. For the avoidance of
doubt, for purposes of the preceding sentence, any performance-vesting Company Option shall become fully vested and exercisable at the applicable target level.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) At least five Business Days prior to the Closing Date, each holder of a Company Option that has an exercise price per share that is
greater than the Cash Consideration shall be provided with written notice by the Company as soon as practicable after the date hereof that such holder shall, during the period beginning on the date of such notice and ending on the Business Day
preceding the Closing Date (the &#147;<B>Exercise Period</B>&#148;), have the right to exercise such Company Option by providing the Company with a notice of exercise and a cash amount equal to the product of (i)&nbsp;the excess of the applicable
per share exercise price of such Company Option over the Cash Consideration multiplied by (ii)&nbsp;the number of Shares subject to such Company Option, with such exercise conditioned on the occurrence of the Closing. Each Company Option that is
exercised pursuant to this Section 2.03(b) shall be settled at the Closing in exchange for, in respect of each Share subject to such Company Option, one CVR. Any Company Option described in this Section&nbsp;2.03(b) that is not exercised during the
Exercise Period or at any other time prior to the closing of the Reorganization (as defined below) shall be cancelled at the closing of the Reorganization for no consideration therefor. The Company shall use reasonable best efforts to take, or cause
to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to effect the transactions contemplated by this Section 2.03(b). For the avoidance of doubt, for purposes of this
Section&nbsp;2.03(b), any performance-vesting Company Option shall become fully vested and exercisable at the applicable target level.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(c) Each restricted Share that is outstanding as of immediately prior to the Closing and
that was granted or issued under any Company Plan (each, a &#147;<B>Company Restricted Share</B>&#148;) and that is validly tendered (and not withdrawn) by the holder of such Company Restricted Share pursuant to the Offer shall become fully vested
as of immediately prior to the Closing, and such tendered Company Restricted Share shall be treated as a validly tendered Share as provided under Section 2.01(d). Any Company Restricted Share that is not validly tendered (or that is withdrawn)
pursuant to the Offer shall remain outstanding after the Closing in accordance with its terms; <B></B><I>provided</I><B></B> that (i)&nbsp;to the extent such Company Restricted Share becomes vested as of the consummation of the Offer, the Asset Sale
or other Reorganization, as applicable, such Company Restricted Share shall be treated in the same way as any other Share that is not tendered in the Offer under the terms of this Agreement and (ii)&nbsp;to the extent such Company Restricted Share
does not become vested as of the consummation of the Offer, the Asset Sale or other Reorganization, as applicable, (x)&nbsp;to the extent not prohibited by the applicable award agreement, the Company shall repurchase such Company Restricted Share at
the consummation of the Offer, the Asset Sale or other Reorganization, as applicable, for a cash payment equal to the issue price of such Company Restricted Share (in which case, the Boards shall take all actions necessary to effect such repurchase
on such terms) and (y)&nbsp;otherwise, the Company Restricted Share shall be cancelled in exchange for the right to receive the Cash Consideration and one CVR.<B> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.04. <I>Extraordinary General Meeting.</I> <I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) On or prior to the Offer Commencement Date, the Company shall duly call, give notice and, as soon as practicable following the date
hereof taking into account a notice period of at least 35 calendar days and that notice will not be given until the Pre-Launch Condition has been satisfied or waived (but in any event prior to the Closing), hold an extraordinary meeting of
shareholders (the &#147;<B>EGM</B>&#148;) to:<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) provide information regarding the Offer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) accept resignations from, and provide discharge to, all but two of the existing members of the Boards and, subject to
Section&nbsp;2.04(f) and Section 2.05, appoint such new members to the Boards as designated by Buyer to replace such resigning directors; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(iii) approve the sale by the Company effective as of the Closing, pursuant to a sale and purchase agreement in
customary form (an &#147;<B>Asset Sale Agreement</B>&#148;), of all of the assets, including any Tax attributes to the extent transferable, and assumption of all liabilities of the Company (including, at the discretion of Buyer, the Company&#146;s
Subsidiaries) to Buyer and/or one or more of its designees for aggregate consideration of <B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>
</B>(A) a note payable (the &#147;<B>Note Payable</B>&#148;) from Buyer or one or more of its designees in an aggregate principal amount equal to the Cash Consideration multiplied by the total
number of outstanding Shares as of the Closing (which Note Payable shall be prepayable without penalty or premium but shall require Buyer to pay to the Company, on or promptly following the completion of the Subsequent Offering Period, an amount of
the Note Payable equal to the Cash Consideration multiplied by the number of outstanding Shares not tendered in the Offer or the Subsequent Offering Period), (B)&nbsp;a note (the &#147;<B>Convertible Note</B>&#148;) from Buyer convertible into an
aggregate amount of CVRs equal to the total number of outstanding Shares as of the Closing (which Convertible Note shall be prepayable without penalty or premium but shall require Buyer to distribute to the Company, on or promptly following the
completion of the Subsequent Offering Period, a number of CVRs equal to the number of Shares not tendered in the Offer or the Subsequent Offering Period, (the &#147;<B>Note Conversion</B>&#148;)) and (C)&nbsp;the assumption by Buyer and/or its
designees of all liabilities and obligations of the Company (including the Company&#146;s Subsidiaries), whether actual, contingent or otherwise, including the express assumption of all contractual obligations (and also including the related
obligation of Buyer or its designees to fully indemnify and hold harmless the Company with respect to all such assumed liabilities and obligations) (the transaction described in this clause (iii)&nbsp;and the Second Step Distribution, the
&#147;<B>Asset Sale</B>&#148;); and <B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(iv) resolve upon the liquidation and dissolution of the Company
following such Asset Sale with the aim that the proceeds of such sale will be distributed by means of a liquidation distribution (which may be an advance distribution, as described in Section 2.04(e)) (the &#147;<B>Second Step
Distribution</B>&#148;) to the shareholders of the Company such that each holder of Shares that were not tendered in the Offer or during the Subsequent Offering Period shall receive cash and CVRs in an amount equal to the Offer Consideration
multiplied by the number of Shares then held by such holder (in the case of the Cash Consideration, without interest, less any applicable withholding taxes with respect to the Offer Consideration). <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Promptly after the date of this Agreement, the Company shall prepare appropriate materials for the EGM (together with any amendments and
supplements thereto and any other required, the &#147;<B>EGM Materials</B>&#148;) relating to the matters set forth in <BR>Section&nbsp;2.04(a). Subject to Section 5.03(e) and Section 5.03(f), the Company shall include the Company Recommendation in
the EGM Materials. Parent and Buyer shall promptly furnish to the Company all information concerning Parent and Buyer required to be set forth in the EGM Materials. The Company shall provide Parent and its counsel with a reasonable opportunity to
review and comment on the EGM Materials each time prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dissemination to the shareholders of the Company and the Company shall give reasonable and good faith consideration to any comments made by Parent and its counsel. The Company shall provide
Parent, Buyer and their counsel, to the extent permitted under Applicable Law, with (i)&nbsp;any comments or other communications, whether written or oral, that the Company or its counsel may receive from time to time from Governmental Authorities
with respect to the EGM Materials promptly after receipt of those comments or other communications and (ii)&nbsp;a reasonable opportunity to participate in the Company&#146;s response to those comments and to provide comments on that response (to
which reasonable and good faith consideration shall be given), including by participating with the Company or its counsel in any discussions or meetings with Governmental Authorities to the extent such participation is permitted by the applicable
Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(c) The Company shall give Parent no less than three Business Days&#146; advance notice of the date which
shall be set as the &#147;record date&#148; for the EGM. The Company shall consult with Parent regarding the date of the EGM and shall not cancel the EGM without the prior written consent of Parent; <I><U>provided</U></I> that the Company may,
following reasonable consultation with Parent, cancel the EGM to the extent reasonably necessary to ensure that any supplement or amendment to EGM Materials that the Company Board, after consultation with outside counsel, reasonably determines is
necessary to comply with Applicable Law, is made available to the Company&#146;s shareholders in advance of the EGM. In the event the EGM is cancelled pursuant to the foregoing proviso, the Company shall duly call, give notice of, and hold the EGM
as soon as practicable following the date of such cancellation.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company shall ensure that the EGM is called, noticed,
convened, held and conducted, in compliance in all material respects with all Applicable Law. The adoption of the matters set forth in Section 2.04(a) shall be the only matters which the Company shall propose to be acted on by the shareholders of
the Company at the EGM, unless otherwise approved in writing by Parent, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Without limiting the generality of
the foregoing or Section 8.01(d)(i), the Company agrees that (i)&nbsp;its obligation to duly call, give notice of, convene and hold the EGM shall not be affected by any Adverse Recommendation Change and (ii)&nbsp;its obligations pursuant to this
Section 2.04 shall not be affected by the commencement, public proposal, public disclosure or communication to the Company of any Acquisition Proposal (whether or not a Superior Proposal). Unless this Agreement is terminated in accordance with
Article 8, the Company agrees that it shall not submit to the vote of the shareholders of the Company any Acquisition Proposal (whether or not a Superior Proposal) prior to the vote of the shareholders of the Company with respect to the matters set
forth in this Section&nbsp;2.04. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(f) In connection with the Asset Sale, Buyer shall provide a guarantee to the liquidator
as to any deficit in the estate of the Company, so as to enable the liquidator to pay the Offer Consideration (in the case of the Cash Consideration, without interest, less any applicable withholding taxes with respect to the Offer Consideration) by
means of an advance liquidation distribution to holders of Shares that were not tendered in the Offer or during the Subsequent Offering Period. The approvals by Company shareholders of the resignations and appointments, the sale of the
Company&#146;s assets, the liquidation and dissolution of the Company and the distribution of the liquidation proceeds referred to in Section 2.04(a) (the &#147;<B>Shareholder Approvals</B>&#148;) will be effective as of, and conditional upon the
occurrence of, the Closing. At the EGM, the Company shall use its reasonable best efforts to secure the Shareholder Approvals, such Shareholder Approvals to be effective as of, and conditional upon, the occurrence of the Closing.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.05. <I>Directors</I>. As soon as practicable after the date of this Agreement, and no later than the Offer Commencement
Date, Buyer shall designate in writing to the Company the new members for the Boards for purposes of Section 2.04(a)(ii) (the &#147;<I></I><B>Buyer Directors</B><I></I>&#148;). For the avoidance of doubt, no fewer than two of the current directors
of the Company (the &#147;<I></I><B>Independent Directors</B><I></I>&#148;), to be mutually agreed upon by the Buyer and the Company, shall remain on the supervisory board of the Company until the earlier of (i)&nbsp;such time after the Closing as
the Buyer owns 100% of the outstanding Shares, (ii)&nbsp;the date the liquidation of the Company shall have been duly completed, or (iii)&nbsp;one year after the date hereof. The Company shall promptly take all actions and shall include in the
Schedule 14D-9 such information with respect to the Company and its officers and directors as any Applicable Law may require in order to fulfill its obligations under Section 2.04. The Company shall take any and all other actions necessary to
appoint the Buyer Directors to the Boards effective immediately following the Closing, and shall take all actions reasonably requested by Parent or Buyer in furtherance thereof. Parent shall supply to the Company in writing and be solely responsible
for any information with respect to itself and its nominees, officers, directors and Affiliates required by any such Applicable Laws. Buyer shall cause all directors of the Company to be discharged at the annual general meeting of the Company held
in 2015 for their acts of management or supervision, as applicable, as appears from the books and records of the Company, provided that no discharge shall have to be granted to a director for acts for which serious blame can be attributed to him or
her (<I>een ernstig verwijt kan worden gemaakt</I>).<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.06<I>. Further Actions</I>. If requested by Parent, the
Company and Buyer shall take as of the date of this Agreement or as soon thereafter as is reasonably practical, but effective no earlier than the Closing, the following actions to the extent reasonably necessary or desirable to accomplish the Asset
Sale and/or the Reorganization: (a)&nbsp;in the case of the Company, the convening of <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
</I>the necessary meetings of the Company shareholders and the Boards (including the EGM referenced in Section 2.04), (b)&nbsp;in the case of the Company, the consideration and approval of
resolutions by the Boards for the purpose of the Reorganization and the consideration and approval of any Board resolutions (the &#147;<I></I><B>Approval of the Boards</B><I></I>&#148;) necessary or desirable to convene the EGM referenced in Section
2.04 and approve the Asset Sale to Buyer or its designee and the liquidation and dissolution of the Company, in each case as set forth in Section 2.04, subject to Section 2.07, and (c)&nbsp;in the case of Buyer and the Company, the execution of any
and all reasonably requested documents, agreements or deeds that are necessary or desirable to effectuate the Reorganization and/or the Asset Sale and the filing or registration of any or all of such documents, agreements or deeds with the
appropriate Governmental Authorities. <I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.07<I>. Reorganization</I>. As promptly as practicable following the
closing of the Subsequent Offering Period, Buyer shall effectuate a corporate reorganization (the &#147;<I></I><B>Reorganization</B><I></I>&#148;) of the Company and its Subsidiaries, which may include, (a)&nbsp;the Asset Sale, which may include, at
Parent&#146;s request, the amendment of the Articles of Association of the Company to permit the creation, among other things, of separate classes of shares in order to effect the foregoing or (b)&nbsp;if permissable under Applicable Law, the
commencement of a compulsory acquisition by Buyer of Shares from any remaining minority shareholder in accordance with Section&nbsp;2:92a of the Dutch Civil Code, in each case, which may be accompanied by the termination of the listing of the Shares
on the NASDAQ and the deregistration of the Company under the 1934 Act and the cessation of the Company&#146;s reporting obligations thereunder. For the avoidance of doubt and notwithstanding anything to the contrary contained in this Section 2.07,
the Reorganization, if completed, shall be conducted in accordance with Applicable Law and shall result in all holders of Shares that were not tendered in the Offer or during the Subsequent Offering Period being offered or receiving in the
Reorganization for each Share then held cash and CVRs in an amount equal to the Offer Consideration (in the case of Cash Consideration, without interest, less applicable withholding taxes with respect to the Offer Consideration), as soon as
reasonably possible after the Closing. If Parent determines it is not reasonably practicable (which shall be deemed to include adverse tax consequences) to effectuate a Reorganization of the type described in clauses (a)&nbsp;or (b)&nbsp;of the
first sentence of this Section 2.07, it will use reasonable best efforts to effectuate a Reorganization in a different manner with the prior approval of the Independent Directors, subject to the immediately foregoing sentence.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.08<I>. Certain Adjustments</I>. Without limiting the other provisions of this Agreement, in the event that, during the
period between the date hereof and the Expiration Time, the number of outstanding Shares or securities convertible or exchangeable into or exercisable for Shares shall be changed into a different number of shares or securities or a different class
as a result of a reclassification, <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
</I>stock split (including a reverse stock split), stock dividend or distribution, recapitalization, merger, issuer tender or exchange offer or other similar transaction, then the Offer
Consideration and any other amounts payable pursuant to this Agreement shall be equitably adjusted, without duplication, to reflect such change; <I>provided</I> that, in any case, nothing in this Section&nbsp;2.08 shall be construed to permit the
Company to take any action with respect to its securities that is prohibited by the terms of this Agreement.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.09. <I>Withholding</I>. Notwithstanding anything to the contrary in this Agreement, each of Parent, Buyer and the
Company shall be entitled to deduct and withhold from the consideration otherwise deliverable under this Agreement, and from any other payments otherwise required pursuant to this Agreement, such amounts as Parent, Buyer, the Company or their
Affiliates may be required to deduct and withhold with respect to any such deliveries (including any deliveries of CVRs) and payments under Applicable Law. To the extent that amounts are so withheld, they shall be treated for all purposes of this
Agreement as having been delivered and paid to such Person in respect of which such deduction and withholding was made.<I> </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 3 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to Section 9.06, except as disclosed in any Company SEC Document filed after December&nbsp;31, 2013 and before the date of this
Agreement (without giving effect to any amendment to any such Company SEC Document filed on or after the date hereof and excluding any disclosures to the extent such disclosures are general cautionary, predictive or forward-looking statements set
forth in any section of a Company SEC Document titled &#147;Risk Factors&#148; or &#147;Forward-Looking Statements&#148;, it being understood that any factual information contained within such sections shall not be excluded) or as set forth in the
Company Disclosure Schedule, the Company represents and warrants to Parent that: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.01. <I>Corporate Existence and Power.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company is duly organized and validly existing under the laws of The Netherlands and has all corporate powers and all governmental
licenses, authorizations, permits, consents and approvals required to own lease and operate its assets and properties and to carry on its business as now conducted, except for any failure to be so organized and existing as and those licenses,
authorizations, permits, consents and approvals the absence of which would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company is duly qualified to do business as a foreign corporation
and is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified or in good standing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company has provided to Parent true and complete copies of its articles of
association and bylaws as in effect as of the date hereof, and as of the date hereof, such articles of association and bylaws are in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) The Company has made available to Parent true and complete (except with respect to any minutes redacted with respect to information
relating to the transactions contemplated by this Agreement (the &#147;<B>Transactions</B>&#148;) and other proprietary business development activities or other confidential information related to third parties in connection with business
development activities of the Company or its Subsidiaries or the process conducted by the Company related to or resulting in the Transactions) copies of the minutes of all meetings of the Supervisory Board since June&nbsp;20, 2012 through the date
hereof and the organizational documents of the Company&#146;s Subsidiaries as in effect on the date hereof. As of the date hereof, the Company Subsidiaries&#146; articles of association, bylaws and other charter and organization documents made
available to the Company are in full force and effect.<B> </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02. <I>Corporate Authorization.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions
contemplated hereby are within the Company&#146;s corporate powers and have been duly authorized by all necessary corporate action on the part of the Company. This Agreement constitutes a valid and binding agreement of the Company, subject to any
applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other Applicable Law affecting creditors&#146; rights generally and general principles of equity (the &#147;<B>Enforceability Exceptions</B>&#148;). The execution
and delivery of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby, including the Offer and the Asset Sale, have been duly and validly authorized by all necessary corporate action, and no other
corporate proceedings on the part of the Company and, except for the approvals to be sought at the EGM as described in Section 2.04(a), no shareholder votes are necessary to authorize this Agreement or to consummate the transactions contemplated
hereby.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) At a meeting duly called and held, the Boards have (i)&nbsp;unanimously determined that this Agreement and the
transactions contemplated hereby are fair to and in the best interests of the Company&#146;s shareholders and other relevant stakeholders, its Subsidiaries and the enterprises carried on by the Company and its Subsidiaries, (ii)&nbsp;unanimously
approved, adopted and declared advisable this Agreement and the transactions contemplated hereby and (iii)&nbsp;unanimously resolved, subject to Sections 5.03(e) and 5.03(f), to recommend acceptance of the Offer by the shareholders of the Company
and to recommend approval and adoption of the matters set forth in Section 2.04(a) (such recommendation, the &#147;<B>Company Recommendation</B>&#148;).<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.03. <I>Governmental Authorization</I>. The execution, delivery and
performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby require no action by or in respect of, or filing by the Company with, any Governmental Authority, other than (i)&nbsp;the filing
of appropriate documents with the relevant authorities of the jurisdictions in which the Company is qualified to do business, (ii)&nbsp;compliance with any applicable requirements of the HSR Act and of laws analogous to the HSR Act existing in
jurisdictions outside of the United States, (iii)&nbsp;compliance with any applicable requirements of the 1933 Act, the 1934 Act and any other applicable securities laws, (iv)&nbsp;compliance with the rules and regulations of the NASDAQ and
(v)&nbsp;any actions or filings the absence of which would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.04. <I>Non-contravention</I>. The execution, delivery and performance by the Company of this Agreement and the
consummation of the transactions contemplated hereby do not and will not (i)&nbsp;contravene, conflict with, or result in any violation or breach of any provision of the articles of association of the Company, (ii)&nbsp;assuming compliance with the
matters referred to in Section&nbsp;3.03, contravene, conflict with or result in a violation or breach of any provision of any Applicable Law or any rules or regulations of NASDAQ in any material respect, (iii)&nbsp;assuming compliance with the
matters referred to in Section 3.03, require any consent or other action by any Person under, constitute a default under, or cause or permit the termination or cancellation of any agreement binding upon the Company or any of its Subsidiaries or
(iv)&nbsp;result in the creation or imposition of any Lien on any asset of the Company or any of its Subsidiaries, with only such exceptions, in the case of each of clauses (iii)&nbsp;through (iv), as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect.<I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.05. <I>Capitalization.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) The authorized capital stock of the Company consists of 87,505,745 Shares and 87,505,745 preferred shares, nominal value
&#128;0.01&nbsp;per share (the &#147;<B>Preferred Shares</B>&#148;). As of November&nbsp;20, 2014, there were outstanding 36,116,179 Shares (including 204,750 of Company Restricted Shares), no Preferred Shares and Company Options to purchase an
aggregate of 2,513,406 Shares. All outstanding shares of capital stock of the Company have been duly authorized and validly issued and fully paid.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in Section 3.05(a) and for changes since November&nbsp;20, 2014 resulting from the exercise of Company Options
outstanding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on such date, there are no issued, reserved for issuance or outstanding (i)&nbsp;shares of capital stock of or other voting securities of or ownership interests in the Company,
(ii)&nbsp;securities of the Company convertible into or exchangeable for shares of capital stock or other voting securities of or ownership interests in the Company, (iii)&nbsp;warrants, calls, options, shares of phantom stock or phantom stock
rights, stock purchase, stock appreciation or other rights or obligations to acquire from the Company, or other obligation of the Company to issue, any capital stock or other voting securities or ownership interests in or any securities convertible
into or exchangeable for capital stock or other voting securities or ownership interests in the Company or (iv)&nbsp;stock options, restricted shares, stock appreciation rights, performance units or similar securities, phantom stock rights or other
rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock or voting securities of the Company (the items in clauses (i)&nbsp;through (iv)&nbsp;being referred to
collectively as the &#147;<B>Company Securities</B>&#148;). There are no preemptive or other outstanding rights, options, warrants, conversion rights, stock appreciation rights, performance units, redemption rights, repurchase rights, agreements,
arrangements, calls, commitments or rights of any kind that obligate the Company to issue or sell any Company Securities, or giving any Person a right to subscribe for or acquire any Company Securities and no securities or obligations evidencing
such rights are authorized, issued or outstanding. Neither the Company nor any of its Subsidiaries maintains an &#147;employee stock purchase plan&#148; within the meaning of Section&nbsp;423 of the Code. Each grant of a Company Option or Company
Restricted Share was properly approved by the Supervisory Board or the Compensation Committee in compliance in all material respects with Applicable Law and were validly issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Section 3.05(c) of the Company Disclosure Schedule sets forth, as of the date of this Agreement, an accurate and complete list of each
outstanding Company Option and Company Restricted Share and (i)&nbsp;the exercise or purchase price thereof, if applicable and (ii)&nbsp;the Company Plan (and the name of any foreign sub-plan) under which each Company Option or Company Restricted
Share was granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) None of the Shares or Company Securities are owned by any Subsidiary of the Company. Except for the Company
Subsidiary Securities, neither the Company nor any of its Subsidiaries owns directly or indirectly any equity interest in any Person, or has any obligation or has made any agreement to acquire any such equity interest, to provide funds to, or to
make any investment (in the form of a loan, capital contribution or otherwise) in, any other Person. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06.
<I>Subsidiaries.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Subsidiary of the Company has been duly organized, is validly existing and (where applicable) in good
standing under the laws of its jurisdiction </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of organization, has all organizational powers and all governmental licenses, authorizations, permits, consents and approvals required to own, lease and operate its assets and properties and to
carry on its business as now conducted, except for any failure to be so organized, existing and in good standing as and for those licenses, authorizations, permits, consents and approvals the absence of which would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect. Each such Subsidiary is duly qualified to do business as a foreign entity and (where applicable) is in good standing in each jurisdiction where such qualification is
necessary, except for those jurisdictions where failure to be so qualified or in good standing would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) All of the outstanding capital stock or other voting securities of, or ownership interests in, each Subsidiary of the Company is
owned by the Company, directly or indirectly, free and clear of any Lien. There are no issued, reserved for issuance or outstanding (i)&nbsp;securities of the Company or any of its Subsidiaries convertible into, or exchangeable for, shares of
capital stock or other voting securities of, or ownership interests in, any Subsidiary of the Company, (ii)warrants, calls, options or other rights to acquire from the Company or any of its Subsidiaries, or other obligations of the Company or any of
its Subsidiaries to issue, any capital stock or other voting securities of, or ownership interests in, or any securities convertible into, or exchangeable for, any capital stock or other voting securities of, or ownership interests in, any
Subsidiary of the Company or (iii)&nbsp;stock options, restricted shares, stock appreciation rights, performance units or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value
or price of, any capital stock or other voting securities of, or ownership interests in, any Subsidiary of the Company (the items in clauses (i)&nbsp;through (iii)&nbsp;being referred to collectively as the &#147;<B>Company Subsidiary
Securities</B>&#148;). There are no preemptive or other outstanding rights, options, warrants, conversion rights, stock appreciation rights, performance units, redemption rights, repurchase rights, agreements, arrangements, calls, commitments or
rights of any kind that obligate the Company or any of its Subsidiaries to issue or sell any Company Subsidiary Securities, or giving any Person a right to subscribe for or acquire any Company Subsidiary Securities and no securities or obligations
evidencing such rights are authorized, issued or outstanding. <B> </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.07. <I>SEC Filings.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company has filed with or furnished to the SEC on a timely basis, and made available to Parent, all reports, schedules, forms,
statements, prospectuses, registration statements and other documents (including exhibits and other information incorporated therein) required to be filed or furnished by the Company (collectively, together with any exhibits and schedules thereto
and other information incorporated therein, the &#147;<B>Company SEC Documents</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As of its filing date, each Company SEC Document complied, and each Company SEC Document
filed subsequent to the date hereof will comply, as to form in all material respects with the applicable requirements of the 1933 Act and the 1934 Act, as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to
such Company SEC Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As of its filing date, each Company SEC Document filed pursuant to the 1934 Act did not, and each Company
SEC Document filed subsequent to the date hereof will not, contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they
were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Company SEC Document that is a registration statement, as amended or supplemented, if applicable,
filed pursuant to the 1933 Act, as of the date such registration statement or amendment became effective, did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company has complied in all material respects with the applicable listing and corporate
governance rules and regulations of NASDAQ. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.08. <I>Financial Statements.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) The Company has made available to Parent copies of the consolidated, unaudited balance sheets of the Company and its Subsidiaries,
together with the related unaudited statements of operations and cash flows as at and for the nine-month period ended September&nbsp;30, 2014 and the notes thereto (together with the audited consolidated financial statements and unaudited
consolidated interim financial statements of the Company included or incorporated by reference in the Company SEC Documents, the &#147;<B>Financial Statements</B>&#148;). <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Financial Statements fairly present, and each Financial Statement filed subsequent to the date hereof will fairly present, in all
material respects, in conformity with IFRS (except as may be indicated in the notes thereto), the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and their consolidated results of operations
and cash flows for the periods then ended (subject to normal year-end audit adjustments and the absence of footnotes in the case of any unaudited interim financial statements). Each of the Financial Statements, at the time of its filing or being
furnished complied or, if not yet filed or furnished, will comply in all material respects with the applicable requirements of the 1933 Act and the 1934 Act and any rules and regulations promulgated thereunder applicable to the Financial Statements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor any of its Subsidiaries is a party to, or has any commitment to
become a party to, any joint venture, off-balance sheet partnership or any similar contract (including any contract or arrangement relating to any transaction or relationship between or among the Company, on the one hand, and any unconsolidated
Affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand), or any &#147;off-balance sheet arrangements&#148; (as defined in Item&nbsp;303(a) of Regulation S-K under the 1934 Act), where the
result, purpose or intended effect of such contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company in its published financial statements or other Company Reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The books and records of the Company and its Subsidiaries have been, and are being, maintained in all material respects in accordance with
IFRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.09. <I>Internal Controls.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As of the date hereof, the Company expects, at or prior to December&nbsp;31, 2014, to have established a system of internal control over
financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the 1934 Act) which is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with IFRS. There were no changes in the Company&#146;s internal control over financial reporting since December&nbsp;31, 2012 that have materially and adversely affected, or are reasonably likely to materially and adversely affect, the
Company&#146;s internal control over financial reporting. Since December&nbsp;31, 2011, none of the Company&#146;s nor, to the knowledge of the Company, the Company&#146;s independent registered accountant has identified or been made aware of:
(x)&nbsp;any illegal act or fraud that involves the Company&#146;s management or other Company Service Provider and that is material to the business of the Company and its Subsidiaries, taken as a whole, or (y)&nbsp;any claim or allegation regarding
any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As of the date hereof, the Company expects, at or prior to December&nbsp;31, 2014, to have established
disclosure controls and procedures required by Rule 13a-15 or 15d-15 under the 1934 Act that are sufficient to ensure that information required to be disclosed by the Company is recorded and reported on a timely basis to the individuals responsible
for the preparation of the Company&#146;s filings with the SEC and other public disclosure documents. The Company has disclosed, based on its most recent evaluation prior to the date of this Agreement, to the Company&#146;s outside auditors and the
audit committee of the Supervisory Board (i)&nbsp;any significant deficiencies or material weaknesses in the design or operation of internal controls over financial reporting (as defined in Rule 13a-15(f) under the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
1934 Act) that are reasonably likely to adversely affect the Company&#146;s ability to record, process, summarize and report financial information and (ii)&nbsp;any fraud, known to the Company
that involves management or other Company Service Providers who have a significant role in the Company&#146;s internal controls over financial reporting and that is material to the business of the Company and its Subsidiaries, taken as a whole. The
Company has made available to Parent true and complete copies of all formal reports regarding internal controls delivered by the Company&#146;s independent auditors to the audit committee of the Supervisory Board since January&nbsp;1, 2012. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.10. <I>Disclosure Documents.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) Each document required to be filed by the Company with the SEC or required to be distributed or otherwise disseminated by the
Company to the Company&#146;s shareholders in connection with the transactions contemplated by this Agreement (the &#147;<B>Company Disclosure Documents</B>&#148;), including the Schedule 14D-9 and the EGM Materials, and any amendments or
supplements thereto, when filed, distributed or disseminated, as applicable, will comply as to form in all material respects with the applicable requirements of the 1934 Act and other Applicable Law governing the preparation, distribution or
dissemination of such documents.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The information with respect to the Company or any of its Subsidiaries that the Company
supplies to Parent for use in the Schedule TO and the Offer Documents, at the time of the filing of the Schedule TO or any amendment or supplement thereto, at the time of any distribution or dissemination of the Offer Documents and at the time of
the consummation of the Offer, will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading. The representations and warranties contained in this Section 3.10 will not apply to statements or omissions included or incorporated by reference in the Company Disclosure Documents, the Schedule TO and the Offer
Documents based upon information supplied by Parent or Buyer or any of their representatives or advisors specifically for use or incorporation by reference therein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.11. <I>Absence of Certain Changes.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From the Company Balance Sheet Date until the date hereof, the business of the Company and its Subsidiaries has been conducted in the
ordinary course consistent with past practices in all material respects and there has not been any event, occurrence, development or state of circumstances or facts that has had or would reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) From the Company Balance Sheet Date until the date hereof, there has not been any action
taken by the Company or any of its Subsidiaries that, if taken during the period from the date of this Agreement through the Closing without Parent&#146;s consent, would constitute a breach of Subsections (a), (b), (d), (e), (f), (g), (h), (m), (n),
(o), (q), (t)&nbsp;or (u)&nbsp;of Section 5.01. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.12. <I>No Undisclosed Material Liabilities</I>. There are no
liabilities or obligations of the Company or any of its Subsidiaries of any kind (whether accrued or not accrued, absolute, contingent or otherwise), other than: (i)&nbsp;liabilities or obligations disclosed and provided for in the Company Balance
Sheet or in the notes thereto; (ii)&nbsp;liabilities or obligations incurred in the ordinary course of business since the Company Balance Sheet Date; (iii)&nbsp;liabilities or obligations incurred in connection with the transactions contemplated
hereby; and (iv)&nbsp;liabilities or obligations that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. <I> </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.13. <I>Compliance with Laws; Regulatory Matters.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries is in compliance with, and since January&nbsp;1, 2010 have been in compliance with, and to the
knowledge of the Company, is not under investigation with respect to and has not been threatened to be charged with or given written notice of any violation of, any Applicable Law, except to the extent that any non-compliance, investigation or
violation would not reasonably be expected to be materially adverse to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) The
Company and each of its Subsidiaries holds all authorizations, licenses, permits, certificates, filings, consents, variances, exemptions, waivers, approvals, orders, registrations and clearances of any Governmental Authority necessary for the
Company and each Subsidiary to own, lease and operate its properties and assets, and to carry on and operate its businesses in all respects as currently conducted (the &#147;<B>Company Permits</B>&#148;), except as would not reasonably be expected
to be materially adverse to the Company and its Subsidiaries, taken as a whole. The Company and each of its Subsidiaries is and since January&nbsp;1, 2010 been in compliance with the terms of the Company Permits in all respects, and all of the
Company Permits are valid and in full force and effect in all respects, except as would not reasonably be expected to be materially adverse to the Company and its Subsidiaries, taken as a whole. As of the date hereof, no suspension, modification,
revocation or cancellation of any of the Company Permits is to the knowledge of the Company pending or threatened, nor, to the knowledge of the Company do reasonable grounds exist for any such action, except as would not reasonably be expected to be
materially adverse to the Company and its Subsidiaries, taken as a whole.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) None of the Company, the Company&#146;s Subsidiaries or any of their respective directors,
officers, employees or, to the Company&#146;s knowledge, agents or representatives of the Company or a Subsidiary (i)&nbsp;has used any corporate funds for any illegal contributions, gifts, entertainment or other unlawful expenses relating to
political activity, (ii)&nbsp;has used any corporate funds for any direct or indirect unlawful payments to any foreign or domestic government officials or employees, (iii)&nbsp;has violated or is violating any provision of the Foreign Corrupt
Practices Act of 1977, the UK Bribery Act of 2010 or any other applicable anticorruption Laws, (iv)&nbsp;has established or maintained any unlawful fund of corporate monies or other properties, (v)&nbsp;has made any bribe, unlawful rebate, payoff,
influence payment, kickback or other unlawful payment of any nature or (vi)&nbsp;violated or operated in noncompliance with any anti-money laundering law, anti-terrorism law or regulation, anti-boycott regulations or embargo regulations, except in
the case of clauses (i)&nbsp;through (vi)&nbsp;as would not reasonably be expected to be materially adverse to the Company and its Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company has made available to Parent accurate and complete copies of (i)&nbsp;the final study reports of all clinical and good
laboratory practice (GLP) non-clinical studies conducted by or on behalf of the Company with respect to each Key Product (other than PRO052, PRO055 and PROSPECT) conducted through the date hereof and (ii)&nbsp;all audit reports relating to the drug
substance, drug product, packaging and supply of drisapersen compiled through the date hereof. To the knowledge of the Company, all required good laboratory practice (GLP) non-clinical studies conducted prior to the date hereof by or on behalf of
the Company with respect to drisapersen were included in a submission to the FDA, the EMA or similar Governmental Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The
Company has delivered or made available to Parent all material forms, licenses, reports, applications, correspondence, and meeting minutes received from or sent to the FDA, the EMA and any other similar Governmental Authority on or after
January&nbsp;1, 2013 through the date hereof relating to each Key Product (other than PRO052, PRO055 and PROSPECT), including any and all written notices of inspectional observations, establishment inspection reports and any other documents received
from the FDA, the EMA or comparable foreign Governmental Authorities (in each case, to the extent received on or after January&nbsp;1, 2013 and prior to the date hereof) which bear in any material way on the Company&#146;s compliance with regulatory
requirements of the FDA, the EMA or comparable foreign Governmental Authorities, or on the likelihood or timing of approval of each Key Product (other than PRO052, PRO055 and PROSPECT). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Neither the Company nor any other Person acting on behalf of or for the benefit of the Company is marketing, distributing, selling or
otherwise commercializing any product on behalf of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Company has not received any written notice or other written communication from the FDA,
the EMA or any other Governmental Authority alleging any material violation of any requirement of Applicable Law, including any failure to maintain systems and programs adequate to ensure compliance with any Applicable Law related to product and
trial quality by the Company. The Company has not received any (i)&nbsp;written notices of inspectional observations (including those recorded on Form FDA 483), establishment inspection reports, warning letters, untitled letters, (ii)&nbsp;written
notices of any intention to conduct an investigation or review, or (iii)&nbsp;other documents issued by the FDA, the EMA or any other Governmental Authority that allege or assert any material lack of compliance with any Applicable Law by the
Company, or by Persons who are otherwise performing services for the benefit of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.14. <I>Litigation</I>.
Except as would not reasonably be expected to be materially adverse to the Company and its Subsidiaries, taken as a whole: (a)&nbsp;there is no material Action pending against, or, to the knowledge of the Company, threatened in writing against, the
Company or any of its Subsidiaries or any property or assets of the Company or any of its Subsidiaries before (or, in the case of threatened Actions, would be before) or by any Governmental Authority; (b)&nbsp;neither the Company nor any of its
Subsidiaries is a party to or subject to the provisions of any material judgment, order, writ, injunction, decree or award of any Governmental Authority specifically imposed upon the Company or any of its Subsidiaries and (c)&nbsp;there are no
internal investigations or internal inquiries that, since January&nbsp;1, 2011, have been conducted by or at the direction of the Boards (or any committee thereof) concerning any financial, accounting or other misfeasance or malfeasance issues or
that would reasonably be expected to lead to a voluntary disclosure or enforcement action.<I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.15.
<I>Properties</I>. <I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as would not have or would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Company and each of its Subsidiaries have good and valid title to, or in the case
of leased property and leased tangible assets, valid leasehold interests in, all of its material real properties and tangible assets. All such material assets and real properties, other than assets and real properties in which the Company or any of
its Subsidiaries has leasehold interests, are free and clear of all material Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Section 3.15(a)(ii) of the
Company Disclosure Schedule sets forth, as of the date of this Agreement, (A)&nbsp;a true and complete list of all real property leased, subleased or otherwise occupied by the Company or any of its Subsidiaries (collectively, the &#147;<B>Leased
Real Property</B>&#148;), (B)&nbsp;the address for each such Leased Real Property and (C)&nbsp;the current rent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
amounts payable by the Company or any of its Subsidiaries related to each such Leased Real Property. No Person other than the Company or its Subsidiary, as applicable, has any right (whether by
lease, sublease, license or otherwise) to use or occupy all or any portion of the Leased Real Property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Company
and its Subsidiaries have a valid and existing interest in the Leased Real Property, and the Company and its Subsidiaries enjoy peaceful and undisturbed possession of the Leased Real Property. The Leased Real Property constitutes all of the real
property used by the Company and its Subsidiaries in the operation of the business of the Company and its Subsidiaries, and such Leased Real Property is sufficient in all material respects for the conduct of the business of the Company and its
Subsidiaries as currently conducted. Neither the Company nor any of its Subsidiaries has received any written notice from any Governmental Authority with respect to the lease, occupancy or use of the Leased Real Property that affects the rights of
the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries has received written notice of any actions in eminent domain, condemnation or other similar actions that are pending, and, to the knowledge of the Company, there
are no such actions threatened, affecting any portion of the Leased Real Property and neither the Company nor any of its Subsidiaries has received written notice of the existence of any outstanding order or of any pending action, and, to the
knowledge of the Company, there is no such order or action threatened, relating to the ownership, lease, use, occupancy or operation by any Person of the Leased Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor any of its Subsidiaries has ever owned any real property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.16<I>. Intellectual Property.</I> <I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Section 3.16(a) of the Company Disclosure Schedule sets forth, as of the date hereof, a true and complete list of all Company Registered
Intellectual Property. For each listed item, Section 3.16(a) of the Company Disclosure Schedule indicates, as applicable, (i)&nbsp;the owner(s) of such Company Registered Intellectual Property, (ii)&nbsp;the countries in which such Company
Registered Intellectual Property is patented or registered or in which an application for same has been filed, (iii)&nbsp;the patent, registration or application number, (iv)&nbsp;the filing and issue dates thereof and (v), in the case of Domain
Names included in such Company Registered Intellectual Property, the registrar therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect: (i)&nbsp;all necessary registration, maintenance and renewal fees due as of the date hereof in respect of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company Registered Intellectual Property have been made, (ii)&nbsp;all necessary documents, recordations and certificates in respect of Company Registered Intellectual Property have been filed
with the relevant Governmental Authorities in the United States or other jurisdictions in which such Company Registered Intellectual Property is registered for the purposes of maintaining such Company Registered Intellectual Property, and
(iii)&nbsp;to the knowledge of the Company, all necessary registration, maintenance and renewal fees due as of the date hereof in respect of any other Registered Intellectual Property exclusively licensed to the Company or its Subsidiaries have been
made and all necessary documents, recordations and certificates in respect of any such Registered Intellectual Property have been filed with the relevant Governmental Authorities in the United States or other jurisdictions in which any such
Registered Intellectual Property is registered for the purposes of maintaining such Registered Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To the
knowledge of the Company, the conduct of the business of the Company and its Subsidiaries as currently conducted or as proposed to be conducted in the Company SEC Documents, does not infringe on or misappropriate the Intellectual Property rights of
any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of the Company, no Person is infringing any Intellectual Property right owned by or exclusively licensed
(for any field, product use or geography) to the Company or its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) None of the Intellectual Property owned by the Company
or any of its Subsidiaries and none of the Intellectual Property exclusively licensed (for any field, product use or geography) to the Company or any of its Subsidiaries is subject to any outstanding judgment, injunction, order or decree restricting
the use thereof by the Company or its Subsidiaries or adjudging such Intellectual Property invalid or unenforceable, in whole or in part, and, to the knowledge of the Company, there are no existing facts or circumstances that would render any such
Intellectual Property invalid or unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Company and its Subsidiaries have taken reasonable steps in accordance with
normal industry practice to maintain the confidentiality of all Intellectual Property owned by the Company or its Subsidiaries, the value of which to the Company and its Subsidiaries is contingent upon maintaining the confidentiality thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) All current or former Company Service Providers who are or were involved in the design, creation, conception, reduction to practice or
development of Intellectual Property for the Company or any of its Subsidiaries have executed written contracts pursuant to which (i)&nbsp;such Company Service Provider agrees to protect the confidentiality of any confidential information included
in such Intellectual Property and (ii)&nbsp;the Company or one of its Subsidiaries has either (A)&nbsp;obtained sole ownership of such Intellectual Property (whether by assignment or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Intellectual Property constituting a &#147;work made for hire&#148; under U.S. copyright laws) or (B)&nbsp;obtained a valid right to exploit such Intellectual Property sufficient for the
conduct of its business as currently conducted or as proposed to be conducted in the Company SEC Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) To the knowledge of the
Company, Glaxo Group Limited has materially completed all transfer obligations set forth in that certain Termination Agreement between the Company and Glaxo Group Limited, effective January&nbsp;12, 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company has provided to Parent a complete and accurate description of the gene sequence associated with each of the Key Products
(other than PRO052, PRO055 and PROSPECT). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17. <I>Taxes</I>. Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All Tax Returns required by Applicable Law to be filed with any
Taxing Authority by, or on behalf of, the Company or any of its Subsidiaries have been filed when due in accordance with all Applicable Law, and all such Tax Returns are, or shall be at the time of filing, correct and complete. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company and each of its Subsidiaries has paid (or has had paid on its behalf) or has withheld and remitted to the appropriate Taxing
Authority all Taxes due (including with respect to amounts paid or owing to any Company Service Provider) and payable, or, where payment is not yet due, has established (or has had established on its behalf and for its sole benefit and recourse) in
accordance with IFRS an adequate accrual for all Taxes through the end of the last period for which the Company and its Subsidiaries ordinarily record items on their respective books. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) There is no Action now pending or, to the Company&#146;s knowledge, threatened, against or with respect to the Company or its Subsidiaries
in respect of any Tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of the Company as of the date hereof, (i)&nbsp;all rights and assets that may give rise to a
material taxable capital gain for Dutch tax purposes upon a sale are owned by Subsidiaries and (ii)&nbsp;no transactions have occurred between the Company and any of the Subsidiaries in the past six calendar years prior to Closing that would give
rise to a material taxable capital gain for Dutch tax purposes upon a sale of the shares in Subsidiaries under the Asset Sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The
Company and its Subsidiaries have received valid decisions from the Dutch Revenue Service (<I>Belastingdienst</I>) as described in article 20b, article 21, and article 21a of the Dutch corporate income tax act for the years 2007, 2008, 2009, 2010
and 2011. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The representations and warranties set forth in this Section 3.17 constitute the only
representations and warranties of the Company in this Agreement with respect to Taxes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.18. <I>Employee Benefit
Plans</I>. <I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Section 3.18(a) of the Company Disclosure Schedule contains a correct and complete list identifying each material
Company Plan. None of the Company or any of its Subsidiaries is expressly or impliedly required to (i)&nbsp;modify, change or terminate any material Company Plan, other than with respect to a modification, change or termination required by
Applicable Law or (ii)&nbsp;adopt, contribute to or sponsor any new plan, policy, program or agreement that would be a material Company Plan if in effect as of the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) For each Company Plan listed on Section 3.18(a) of the Company Disclosure Schedule, subject to Applicable Law, the Company has made
available to Parent complete and accurate copies of, to the extent applicable, (i)&nbsp;such Company Plan (or, if such Company Plan is not written, a written summary of its material terms), including all plan documents, trust agreements, insurance
contracts or other funding vehicles and all amendments thereto, (ii)&nbsp;all summary plan descriptions, including any summary of material modifications, (iii)&nbsp;the most recent annual report with any required schedules filed with the applicable
Governmental Authority with respect to such Company Plan, (iv)&nbsp;the most recent actuarial report or other financial statement relating to such Company Plan, (v)&nbsp;the most recent determination or opinion letter, if any, issued by the
applicable Governmental Authority with respect to such Company Plan and any pending request for such a determination or opinion letter, and (vi)&nbsp;all material filings made with any Governmental Authority within the past three years, including
any filings under a government-sponsored amnesty, voluntary compliance or similar program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected
to be materially adverse to the Company and its Subsidiaries, taken as a whole, each Company Plan has been maintained in compliance with its terms and all Applicable Law. With respect to the Company Plans, no event has occurred and there exists no
condition or set of circumstances in connection with which the Company or any of its Subsidiaries (or, to the knowledge of the Company, any Company Plan fiduciary that is a Company Service Provider) is reasonably likely to be subject to any material
liability (other than for routine claims for benefits) under the terms of, or with respect to, such Company Plans or Applicable Law. As of the date of this Agreement, neither the negotiation nor consummation of the transactions contemplated by this
Agreement is reasonably likely to give rise to any material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liability (other than for routine claims for benefits) under the terms of, or with respect to, such Company Plans or Applicable Law. Except as would not reasonably be expected to be materially
adverse to the Company and its Subsidiaries, taken as a whole, each Company Plan (i)&nbsp;if intended to qualify for special Tax treatment as of the date of this Agreement, meets the requirements for such treatment and (ii)&nbsp;if required to be
funded, book-reserved or secured by an insurance policy, is, as of the date of this Agreement, fully funded, book-reserved or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable
accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) No Company Plan provides any post-retirement medical, dental or life insurance benefits to any current or
former Company Service Provider (other than coverage to the extent mandated by Applicable Law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No Action (other than routine claims
for benefits) is pending against or involves or, to the Company&#146;s knowledge, is threatened against or threatened to involve, any Company Plan before any Governmental Authority which Actions would reasonably be expected to be materially adverse
to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.19. <I>Employee and Labor Matters</I>.<I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Neither the Company nor any of its Subsidiaries is a party to or subject to, voluntarily applies, or is currently negotiating in connection
with entering into, any collective bargaining agreement, social plan or other agreement with any labor union, labor organization or works council, and no such contract is presently being negotiated. To the knowledge of the Company, there are no
current and there has not been at any time during the last three years any campaign or other union organizing activity to authorize representation by any labor union or labor organization with respect to any Company Service Provider. There are no
current and there have not been any labor strikes, slowdowns, work stoppages, lockouts or any similar activity or dispute affecting the Company or any of its Subsidiaries during the last three years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) Except as would not be materially adverse to the Company and its Subsidiaries taken as a whole, the Company and each of its
Subsidiaries is in compliance in all material respects with all Applicable Laws relating to employment and employment practices, terms and conditions of employment, immigration, workers&#146; compensation, long term disability, occupational safety,
plant closings, compensation and benefits, and wages and hours (&#147;<B>Employment Practices</B>&#148;).<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as would not
reasonably be expected to be materially adverse to the Company and its Subsidiaries, taken as a whole, to the knowledge of the Company, as of the date of this Agreement, (i)&nbsp;there are no Actions
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pending or scheduled by any Governmental Authority pertaining to the Employment Practices of the Company or any of its Subsidiaries; and (ii)&nbsp;no complaints relating to Employment Practices
of the Company or any of its Subsidiaries have been filed with any Governmental Authority or submitted in writing to the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of the Company, no Company Service Provider is in material violation of any term of any employment contract,
non-disclosure or confidentiality agreement, noncompetition agreement, or any restrictive covenant to a former employer relating to the right of any such individual to be employed or retained by the Company or any of its Subsidiaries by which the
individual is employed or retained because of the nature of the business conducted or presently proposed to be conducted by it or to the use of trade secrets or proprietary information of others. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No Company Service Provider who is or may become eligible to receive severance benefits under any Company Plan has terminated employment
or been terminated by the Company or any of its Subsidiaries in the six months prior to the date of this Agreement, in either case under circumstances that have given, or could give, rise to a severance obligation on the part of the Company or any
of its Subsidiaries under such Company Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) To the Company&#146;s knowledge, as of the date of this Agreement, no Company Service
Provider holding the position of Director or above has terminated or has advised the Company or any of its Subsidiaries in writing of his or her intention to terminate his or her relationship or status as a Company Service Provider for any reason,
including because of the consummation of the transactions contemplated by this Agreement, and the Company and its Subsidiaries have no plans or intentions as of the date of this Agreement to terminate any such Company Service Provider. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.20. <I>Environmental Matters</I>. Except as would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect:<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) no notice, order, complaint, violation, allegation or liability or penalty has been
received by the Company or any of its Subsidiaries arising out of any Environmental Laws, and there are no judicial, administrative or other Actions pending or, to the Company&#146;s knowledge, threatened which allege a violation by the Company or
any of its Subsidiaries of any Environmental Laws or allege liability of the Company or any of its Subsidiaries pursuant to any Environmental Law; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Company and each of its Subsidiaries have all environmental permits necessary for their
operations to comply with all applicable Environmental Laws and are in compliance with the terms of such permits; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the operations of
the Company and each of its Subsidiaries are in compliance with the terms of applicable Environmental Laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) the Company has made
available to Buyer true and correct copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, engineering studies and environmental studies or assessments in the possession of
the Company or any of their representatives or advisors related to any property currently or formerly used by the Company or any of its Subsidiaries; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Except as set forth in this Section 3.20, no representations or warranties are being made by the Company with respect to matters arising
under or relating to environmental matters, including any matters arising under Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.21<I>. Material
Contracts. </I>Section 3.21 of the Company Disclosure Schedule sets forth, as of the date of this Agreement, a true and complete list of each Contract of the Company or any of its Subsidiaries in effect as of the date of this Agreement and that is
included within any of the following categories: <I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) is a &#147;material contract&#148; (as such term is defined in
Item&nbsp;601(b)(10) of Regulation S-K of the SEC); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) that (i)&nbsp;contains any non-compete or exclusivity provisions including with
respect to marketing, manufacturing, supply or distribution rights (or obligates the Company or any Affiliates to enter into any noncompete or exclusivity arrangements) with respect to any line of business, geographic area or other conduct with
respect to the Company or any of its Affiliates or (ii)&nbsp;requires or obligates the Company or any Affiliates to perform or conduct research, clinical trials or development for the benefit of any person other than the Company or any Affiliates;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) (i) containing any standstill or similar agreement pursuant to which the Company or its Subsidiaries has agreed not to acquire assets
or securities of another Person or (ii)&nbsp;containing a put, call or right of first refusal pursuant to which the Company or its Subsidiaries could be required to purchase or sell, or otherwise acquire or transfer, as applicable, any equity
interests or assets of any Person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) that would prevent, materially delay or materially impede the Company&#146;s ability to
consummate the Offer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) that is between the Company or its Subsidiaries, on the one hand, and either (i)&nbsp;a director, officer,
employee or leased employee of the Company or any of its Subsidiaries (that is not a Company Plan) or (ii)&nbsp;any Person beneficially owning 5% or more of the outstanding Shares, on the other; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) that involves annual expenditures in excess of &#128;500,000 in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) that relates to a partnership, joint venture or similar arrangement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) that relates to the borrowing of money or extension of credit, in each case in excess of &#128;1,000,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) that is material to the business of the Company and its Subsidiaries, taken as a whole, and relates to research, clinical trial,
development, distribution, sale, supply, license, marketing, co-promotion or manufacturing by third parties of the Key Products (other than PRO052, PRO055 and PROSPECT); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) that includes a license, sublicense (of any tier), covenant not to sue, covenant not to assert, or immunity from suit under any
Intellectual Property rights material to the business of the Company and its Subsidiaries, taken as a whole, other than such Contracts licensing to the Company or any of its Subsidiaries commercially available off the shelf software on a
non-exclusive basis; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) that involves the payment by the Company or its Subsidiaries of royalties, milestones or similar payments which
could total in excess of &#128;1,000,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) that requires future material payments by the Company or any of its Subsidiaries as a
result of any &#147;change of control&#148; or similar provisions contained therein, other than any Company Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) that contains a
&#147;right of first refusal&#148;, &#147;right of first offer&#148;, &#147;right of first negotiation&#148; or similar provision relating to any material asset of the Company; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) lease agreements or other material agreements that relate to the Leased Real Property (each, a &#147;<B>Material Contract</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as would not reasonably be expected to be materially adverse to the Company and its Subsidiaries, taken as a whole, (i)&nbsp;each of the Material
Contracts and Company Plans, if a contract or agreement, is a legal, valid and binding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement of the Company or its Subsidiary, as the case may be, and, to the knowledge of the Company, of each other party thereto, enforceable against the Company or such Subsidiary, as the case
may be, and to the knowledge of the Company, each other party thereto, subject to the Enforceability Exceptions and (ii)&nbsp;each of the Company and its Subsidiaries has performed or is performing in all respects all obligations required to be
performed by it under the Material Contracts and the Company Plans and is not in breach or default thereunder, and has not waived or failed to enforce any rights or benefits thereunder, and no event has occurred which, with or without notice, lapse
of time, or both, would constitute a default under the provisions of such Material Contract or Company Plan or would give to others any right of termination, amendment or cancellation. Prior to the date hereof, the Company has delivered or made
available to Parent a true and correct copy of each Material Contract (including all amendments, modifications, extensions and renewals thereof and waivers that are material to such Material Contract). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.22<I>. Finders&#146; Fees. </I>Except for Citigroup Global Markets Inc., there is no investment banker, broker, finder
or other intermediary that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who might be entitled to any fee or commission from the Company or any of its Affiliates in connection with the transactions
contemplated by this Agreement. <I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.23<I>. Opinion of Financial Advisor. </I>The Company has received the
opinion of Citigroup Global Markets Inc., financial advisor to the Company, to the effect that, as of the date of this Agreement and based upon and subject to the factors, assumptions and qualifications set forth therein, the consideration to be
received pursuant to the Offer and the Reorganization is fair to the Company&#146;s shareholders from a financial point of view. The Company will deliver to Parent for informational purposes a signed copy of such opinion as soon as practicable
following the date hereof.<I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.24. <I>Insurance</I>. <I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Section 3.24(a) of the Company Disclosure Schedule sets forth a list of each material insurance policy under which the Company or its
Subsidiaries is an insured or otherwise the principal beneficiary of coverage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect: (i)&nbsp;as of the date of this Agreement, there is no claim pending under any of the Company&#146;s or its Subsidiaries&#146; insurance policies or fidelity bonds as to which
coverage has been questioned, denied or disputed, in whole or in part, by the underwriters of such policies or bonds, (ii)&nbsp;no event has occurred which, with notice or lapse of time, would constitute a breach or default, or permit termination or
modification, under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any such policy or bond and (iii)&nbsp;no written notice of cancellation or termination has been received with respect to any such insurance policy, other than in connection with ordinary
renewals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.25. <I>Transactions with Affiliates</I>. Between the Company Balance Sheet Date and the date of this
Agreement, there is no transaction, or series of similar transactions, agreements, arrangements or understandings, nor is there any proposed transaction or series of similar transactions, agreements, arrangements or understandings to which the
Company or any of its Subsidiaries was or is to be a party that would be required to be reported by the Company pursuant to Item&nbsp;404 of Regulation S-K promulgated by the SEC. <I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.26<I>. Anti-Takeover Measures</I>. No anti-takeover measure (such as the issuance of preference shares or any other
measure which would qualify as a &#147;<I>beschermingsmaatregel</I>&#148; under Netherlands law) that may be invoked or implemented by the Company (or any of its Affiliates) or by a Third Party pursuant to a right granted to such third party by the
Company (or any of its Affiliates) (each an &#147;<I></I><B>Anti-Takeover Measure</B><I></I>&#148;) has been implemented by the Company (or such Affiliate) in relation to the Offer or the Tender Agreements.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.27<I>. No Other Representations and Warranties. </I>Except for the representations and warranties set forth in Article
4, the Company acknowledges and agrees that no representation or warranty of any kind whatsoever, express or implied, at law or in equity, is made or shall be deemed to have been made by or on behalf of Parent or Buyer to the Company, and Parent and
Buyer hereby disclaim any such representation or warranty, whether by or on behalf of Parent or Buyer, and notwithstanding the delivery or disclosure to the Company, or any its Representatives or Affiliates of any documentation or other information
by Parent or Buyer or any of their respective Representatives or Affiliates with respect to any one or more of the foregoing.<I> </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 4 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> P<SMALL>ARENT</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parent represents and warrants to the Company that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.01. <I>Corporate Existence and Power</I>. Each of Parent and Buyer is duly organized, validly existing and in (where
applicable) good standing under the laws of its jurisdiction of organization and has all corporate powers and all governmental licenses, authorizations, permits, consents and approvals required to carry on its business as now conducted, except for
any failure to be so organized, existing and in good standing as and those licenses, authorizations, permits, consents and approvals the absence of which would not reasonably be expected to have, individually or in the aggregate, a Parent Material
Adverse Effect. Since the date of its incorporation, Buyer has not engaged in any activities other than in <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with or as contemplated by this Agreement. Buyer was organized solely for the purpose of consummating the Offer and the transactions contemplated by this Agreement. All of the
outstanding shares of capital stock of Buyer have been validly issued, are fully paid and nonassessable and are owned by, and at the Closing will be owned by, Parent, free and clear of all Liens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.02. <I>Corporate Authorization</I>. The execution, delivery and performance by Parent and Buyer of this Agreement and,
in the case of Parent, the CVR Agreement and the consummation by Parent and Buyer of the transactions contemplated hereby and in the case of Parent, thereby are within the corporate powers of Parent and Buyer and have been duly authorized by all
necessary corporate action of Parent and Buyer. This Agreement and, in the case of Parent, the CVR Agreement upon execution will constitute constitutes a valid and binding agreement of each of Parent and Buyer, as applicable, subject to the
Enforceability Exceptions.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.03. <I>Governmental Authorization</I>. The execution, delivery and performance by
Parent and Buyer of this Agreement and, in the case of Parent, the CVR Agreement and the consummation by Parent and Buyer of the transactions contemplated hereby and, in the case of Parent, thereby require no action by or in respect of, or filing by
Parent or Buyer with, any Governmental Authority, other than (i)&nbsp;the filing of appropriate documents with the relevant authorities of the jurisdictions in which Parent is qualified to do business, (ii)&nbsp;compliance with any applicable
requirements of the HSR Act and of laws analogous to the HSR Act existing in jurisdictions outside of the United States, (iii)&nbsp;compliance with any applicable requirements of the 1933 Act, the 1934 Act and any other applicable securities laws,
(iv)&nbsp;compliance with the rules and regulations of any national securities exchange on which securities of Parent are listed and (v)&nbsp;any actions or filings the absence of which would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.04. <I>Non-contravention</I>. The execution, delivery and
performance by Parent and Buyer of this Agreement and, in the case of Parent, the CVR Agreement and the consummation by Parent and Buyer of the transactions contemplated hereby and, in the case of Parent, thereby do not and will not
(i)&nbsp;contravene, conflict with, or result in any violation or breach of any provision of the organizational documents of Parent or Buyer, (ii)&nbsp;assuming compliance with the matters referred to in Section 4.03, contravene, conflict with, or
result in a violation or breach of any provision of any Applicable Law, (iii)&nbsp;assuming compliance with the matters referred to in Section 4.03, require any consent or other action by any Person under, constitute a default under, or cause or
permit the termination or cancellation of any agreement binding upon Parent or any of its Subsidiaries or (iv)&nbsp;result in the creation or imposition of any Lien on any asset of Parent or any of its Subsidiaries, with only such exceptions, in the
case of each of <I></I>clauses (ii)&nbsp;through (iv), as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.05. <I>Disclosure Documents.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The information with respect to Parent and any of its Subsidiaries that Parent supplies to the Company for use in any Company Disclosure
Document will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading at the time of the filing of such Company Disclosure Document or any supplement or amendment thereto and at the time of any distribution or dissemination thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Schedule TO, when filed, and the Offer Documents, when distributed or disseminated, will comply as to form in all material respects
with the applicable requirements of the 1934 Act and, at the time of such filing or the filing of any amendment or supplement thereto, at the time of such distribution or dissemination and at the time of consummation of the Offer, will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The representations and
warranties in this Section 4.05 will not apply to statements or omissions included or incorporated by reference in the Schedule TO and the Offer Documents based upon information supplied to Parent or Buyer by the Company or any of its
representatives or advisors specifically for use or incorporation by reference therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06. <I>Finders&#146; Fees.</I>
Except for Bank of America Merrill Lynch, whose fees will be paid by Parent, there is no investment banker, broker, finder or other intermediary that has been retained by or is authorized to act on behalf of Parent who might be entitled to any fee
or commission from the Company or any of its Affiliates in connection with the transactions contemplated by this Agreement and the CVR Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07. <I>Financing.</I> Parent has available, and will have available to it at and as of the time the Closing is required to
occur pursuant to Section 2.01, immediately available funds to enable it to consummate the Offer and the other transactions contemplated by this Agreement pursuant to the terms of this Agreement, including to pay the Cash Consideration for all of
the Shares on a fully diluted basis, to make all payments in respect of the Company Options and Company Restricted Shares and to pay all related fees and expenses of Parent and its Representatives pursuant to this Agreement. Parent has available,
and will have available to it as of the time any amounts are payable under the CVR Agreement, immediately available funds to enable it to make all payments that may become due under the CVR Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.08. <I>Litigation</I>. As of the date hereof, there is no Action pending
against, or, to the knowledge of Parent, threatened in writing against, Parent or any of its Subsidiaries before (or, in the case of threatened Actions, would be before) or by any Governmental Authority, except as would not reasonably be expected to
have, individually or in the aggregate, a Parent Material Adverse Effect.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.09. <I>Ownership of Shares;
Investment</I>. As of the date hereof, neither Parent nor Buyer or any of their Subsidiaries beneficially owns any Shares. The Buyer is acquiring the Convertible Note (or the underlying Conversion Shares) for its own account and not with a view
towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under the 1933 Act or under an exemption from such registration and in compliance with applicable federal and state securities
laws, and the Buyer does not have a present arrangement to effect any distribution of the Convertible Note (or the underlying Conversion Shares) to or through any Person. <I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.10. <I>Absence of Certain Agreements</I>. As of the date hereof, neither Parent nor any of its Affiliates has entered
into any contract, arrangement or understanding (in each case, whether oral or written), or authorized, committed or agreed to enter into any contract, arrangement or understanding (in each case, whether oral or written), pursuant to which:
(a)&nbsp;any shareholder of the Company would be entitled to receive consideration of a different amount or nature than the Offer Consideration or pursuant to which any shareholder of the Company agrees to tender their Shares into the Offer or
(b)&nbsp;any Third Party has agreed to provide, directly or indirectly, equity capital to Parent or the Company to finance in whole or in part the Offer or the other transactions contemplated by this Agreement.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.11. <I>Management Agreements</I>. Other than this Agreement, as of the date hereof, there are no contracts,
undertakings, commitments, agreements or obligations or understandings between Parent or Buyer or any of their Affiliates, on the one hand, and any member of the Company&#146;s management or the Boards, on the other hand, relating in any way to the
transactions contemplated by this Agreement or the operations of the Company after the Closing.<I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.12. <I>No Other
Representations and Warranties.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except for the representations and warranties set forth in Article 3, each of Parent and Buyer
acknowledges and agrees that no representation or warranty of any kind whatsoever, express or implied, at law or in equity, is made or shall be deemed to have been made by or on behalf of the Company to Parent or Buyer, and the Company hereby
disclaims any such representation or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
warranty, whether by or on behalf of the Company, and notwithstanding the delivery or disclosure to Parent or Buyer, or any of their Representatives or Affiliates of any documentation or other
information by the Company or any of its Representatives or Affiliates with respect to any one or more of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of
Parent and Buyer also acknowledges and agrees that the Company makes no representation or warranty with respect to any projections, forecasts or other estimates, plans or budgets of future revenues, expenses or expenditures, future results of
operations (or any component thereof), future cash flows (or any component thereof) or future financial condition (or any component thereof) of the Company or any of its Subsidiaries or the future business, operations or affairs of the Company or
any of its Subsidiaries heretofore or hereafter delivered to or made available to Parent, Buyer or their respective Representatives or Affiliates. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 5 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company agrees that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;5.01<I>. Conduct of the Company</I>. Except with the prior written consent of Parent (which consent shall not be
unreasonably withheld, conditioned or delayed) or as expressly contemplated by this Agreement, or as set forth in Section 5.01 of the Company Disclosure Schedule or as required by Applicable Law, from the date hereof until the Closing, the Company
shall, and shall cause each of its Subsidiaries to, conduct its business in the ordinary course and use its commercially reasonable efforts to preserve intact its business organizations and relationships with Third Parties (including applicable
Governmental Authorities) and to keep available the services of its present officers and key employees. The Company shall not, and shall cause its Subsidiaries not to, from the date of this Agreement to the Closing, take any action or knowingly fail
to take any action that is intended to, or would reasonably be expected to, individually or in the aggregate, prevent, materially delay or materially impede the ability of Parent and Buyer to consummate the Offer. Without limiting the generality of
the foregoing, except with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed) or as expressly contemplated by this Agreement or set forth in Section 5.01 of the Company Disclosure Schedule
or as required by Applicable Law, from the date hereof until the Closing, the Company shall not, nor shall it permit any of its Subsidiaries to:<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) amend its articles of association, bylaws or other similar organizational documents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) split, combine, subdivide, exchange or reclassify any shares of its capital stock or other equity interests, (ii)&nbsp;declare, set
aside or pay any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dividend or other distribution (whether in cash, stock or property or any combination thereof) in respect of its capital stock or authorize the issuance of any other securities in respect of, in
lieu of, or in substitution for, shares of its capital stock or other equity interests, except for dividends by any of its wholly owned Subsidiaries to the Company or other wholly owned Subsidiaries, (iii)&nbsp;redeem, repurchase or otherwise
acquire or offer to redeem, repurchase, or otherwise acquire any Company Securities or any Company Subsidiary Securities, except as required by the terms of any Company Plan, or (iv)&nbsp;enter into any contract, agreement or understanding with
respect to the voting or registration of its capital stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) (i) issue, pledge, dispose, grant, transfer, encumber (or otherwise cause
to be subject to any Lien), deliver or sell, or authorize the issuance, pledge, disposition, grant, transfer, delivery or sale of, any shares of any Company Securities or Company Subsidiary Securities, other than the issuance of (A)&nbsp;any Shares
upon the exercise of Company Options that are outstanding on the date of this Agreement in accordance with the terms of such Company Options as of the date of this Agreement and (B)&nbsp;any Company Subsidiary Securities to the Company or any other
wholly owned Subsidiary of the Company or (ii)&nbsp;adjust or amend the rights of or any term of any Company Security (including Company Options) or any Company Subsidiary Security; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) acquire (by merger, consolidation, acquisition of stock or assets or otherwise), directly or indirectly, any material amount of assets,
securities, properties, interests or businesses, other than acquisitions of supplies and inventories in the ordinary course of business consistent with past practice; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) sell, lease, license, mortgage, encumber (or otherwise subject to any Lien), divest, cancel, abandon or allow to lapse or expire or
otherwise transfer or dispose of any of its assets, securities, properties, interests or businesses (other than Intellectual Property which is the subject of clauses (f)&nbsp;and (g)) that are material, individually or in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) sell, lease, license, transfer, pledge, encumber or dispose of (whether by merger, consolidation, purchase, sale or otherwise) any
Intellectual Property owned by or licensed to the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) abandon, cancel, let lapse, allow to be
dedicated to the public domain, fail to renew, or fail to continue to prosecute, protect or defend any Intellectual Property owned by or licensed to the Company or any of its Subsidiaries, in each case other than in the ordinary course of business
consistent with past practice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) make any loans, advances or capital contributions to, or investments in, any other Person (other than
loans or advances among the Company and any of its wholly owned Subsidiaries and capital contributions to or investments in its wholly owned Subsidiaries); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) incur, create, assume or otherwise become liable for any indebtedness for borrowed money or
guarantees thereof (directly, contingently or otherwise), other than (i)&nbsp;incurred between the Company and any of its wholly owned Subsidiaries or between any of such wholly owned Subsidiaries or guarantees by the Company of indebtedness of any
wholly owned Subsidiary of the Company or (ii)&nbsp;incurred in the ordinary course of business consistent with past practice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) except
as required under the terms of any Company Plan listed on Section 3.18(a) of the Company Disclosure Schedule in effect on the date hereof, (i)&nbsp;increase the compensation or benefits of any Company Service Provider, except for annual increases in
base salary or benefits in the ordinary course of business consistent with past practice, (ii)&nbsp;grant any rights to severance, termination pay, retention or change in control benefit to any current or future Company Service Provider,
(iii)&nbsp;pay or award any bonus or incentive compensation to any Company Service Provider, except as provided in Section 5.01(j) of the Company Disclosure Schedule, (iv)&nbsp;establish, adopt, enter into or amend any material Company Plan or any
plan, policy, program or agreement that would be a material Company Plan if in existence on the date hereof, (v)&nbsp;amend or waive any performance or vesting criteria or accelerate the vesting or lapsing of restrictions with respect to any
compensation, benefits, equity-based compensation, incentive compensation or the forgiveness of indebtedness of any loan, other than with respect to the treatment of Company Options and Company Restricted Shares in accordance with Section 2.03,
(vi)&nbsp;terminate the employment of any Company Service Provider holding the position of Director or above other than for &#147;cause&#148; or (vii)&nbsp;waive or materially amend any restrictive covenant entered into by any Company Service
Provider; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) (i)&nbsp;terminate any Material Contract (other than terminations pursuant to existing terms), (ii)&nbsp;enter into any
contract that, if in effect as of the date hereof, would constitute a Material Contract, or (iii)&nbsp;modify, amend or waive, release or assign any material rights or claims under any Material Contract or any contract that, if in effect as of the
date hereof, would constitute a Material Contract; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) make or commit to any capital expenditure, except for capital expenditures which,
in the aggregate, do not exceed &#128;250,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) cancel any material indebtedness owed to the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) pay, discharge, compromise, settle or satisfy any Action requiring payments by the Company or any of its Subsidiaries in excess of
&#128;50,000 in any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
individual case or series of related cases or &#128;100,000 in the aggregate, other than (i)&nbsp;claims reserved against in the Company Balance Sheet or (ii)&nbsp;payments, discharges,
compromises, settlements or satisfactions that do not exceed the Company&#146;s insurance coverage for such claim; provided that, in each case, the discharge, settlement or satisfaction of such Action does not include any material obligation (other
than the payment of money) to be performed by the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) convene any general or special meeting of the
shareholders of the Company other than a EGM pursuant to Section 2.04 (unless such a meeting is required by Applicable Law); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) write
up, write down or write off the book value of any assets, in the aggregate, in excess of &#128;50,000, except (i)&nbsp;for depreciation and amortization in accordance with IFRS consistently applied, (ii)&nbsp;as otherwise required under IFRS
(including to increase any reserves for contingent liabilities), or (iii)&nbsp;in the ordinary course of business consistent with past practice as may be consistent with IFRS; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) change the Company&#146;s methods of accounting, except as required by concurrent changes in IFRS or in Regulation S-X of the 1934 Act, as
agreed to by its independent public accountants; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) make or change any material Tax election, change any annual tax accounting period,
adopt or change any method of tax accounting, materially amend any Tax Returns or file claims for material Tax refunds, enter into any material closing agreement, settle any material Tax claim, audit or assessment, or surrender any right to claim a
material Tax refund, offset or other reduction in Tax liability, or take any action that would reasonably be likely to affect the availability of net operating loss carry-forwards to the Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) withdraw or modify, or permit the withdrawal or modification of, the Compensation Arrangement Approvals; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) adopt a plan or agreement of complete or partial liquidation, dissolution, restructuring, recapitalization, merger or other reorganization
(other than as contemplated by Section 2.04 or Section 2.07 of this Agreement); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) form or commence the operation of any business or any
partnership, joint venture or other similar business organization or enter into any new line of business that is material to the Company and its Subsidiaries, taken as a whole; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) adopt or implement any Anti-Takeover Measure; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) agree, resolve or commit to do any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02. <I>Access to Information</I>. From the date hereof until the Closing and
subject to Applicable Law and the confidentiality agreement dated as of July&nbsp;31, 2014 between the Company and Parent (the &#147;<B>Confidentiality Agreement</B>&#148;), the Company shall (i)&nbsp;give Parent, its counsel, financial advisors,
auditors and other authorized Representatives, upon reasonable notice, reasonable access to the offices, properties, books and records of the Company and its Subsidiaries, (ii)&nbsp;furnish to Parent, its counsel, financial advisors, auditors and
other authorized representatives such financial and operating data and other information as such Persons may reasonably request and (iii)&nbsp;instruct its employees, counsel, financial advisors, auditors and other authorized representatives to
cooperate reasonably with Parent in its investigation of the Company and its Subsidiaries. Any investigation pursuant to this Section shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the Company
and its Subsidiaries. Nothing in this Section 5.02 shall require the Company to provide any access, or to disclose any information (i)&nbsp;if providing such access or disclosing such information would violate any Applicable Law (including antitrust
and privacy laws) or binding agreement entered into prior to the date of this Agreement or (ii)&nbsp;protected by attorney-client privilege to the extent such privilege cannot be reasonably protected by the Company through exercise of its reasonable
efforts. If any material is withheld by the Company pursuant to the immediately preceding sentence, to the extent permitted by Applicable Law, the Company shall inform Parent as to the general nature of what is being withheld and the basis for
withholding such material and shall use commercially reasonable efforts to make substitute arrangements so as to provide Parent and its Representatives with such access. No such access, nor any information obtained therefrom, shall be deemed to cure
any breach of any representation or warranty made in this Agreement or have any effect for purposes of determining satisfaction of the conditions set forth in this Agreement, or the compliance with any covenant set forth herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03. <I>No Solicitation; Other Offers.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) Neither the Company nor any of its Subsidiaries shall, nor shall the Company or any of its Subsidiaries permit any of its or their
officers, directors, employees, investment bankers, attorneys, accountants, consultants or other agents or advisors (&#147;<B>Representatives</B>&#148;) to, directly or indirectly:<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) solicit, initiate or knowingly take any action to knowingly induce, facilitate or encourage the submission or announcement
of an Acquisition Proposal or any inquiry, indication of interest, proposal or offer that would reasonably be expected to lead to an Acquisition Proposal (including by way of furnishing or providing access to non-public information to a Third
Party); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) enter into or participate in any discussions or negotiations with any Third
Party with respect to an Acquisition Proposal or any inquiry, indication of interest, proposal or offer that would reasonably be expected to lead to an Acquisition Proposal; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) furnish any information relating to the Company or any of its Subsidiaries or afford access to the business, properties,
assets, books or records of the Company or any of its Subsidiaries to or otherwise knowingly cooperate in any way with any Third Party that has made an Acquisition Proposal or any inquiry, indication of interest, proposal or offer that would
reasonably be expected to lead to an Acquisition Proposal; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(iv) enter into any agreement in principle, letter of
intent, term sheet, merger agreement, acquisition agreement, option agreement, joint venture agreement, partnership agreement or other similar instrument relating to, or that is intended to or would be reasonably likely to lead to, an Acquisition
Proposal, or requiring the Company to abandon, terminate, materially delay or fail to consummate, or that would otherwise materially impede, interfere with or be inconsistent with, the transactions contemplated by this Agreement (an
&#147;<B>Alternative Acquisition Agreement</B>&#148;). <B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(b) Notwithstanding Section 5.03(a), at any time prior to the
Closing Date, the Company, directly or indirectly through its Representatives, may engage in negotiations or discussions with, or furnish non-public information to, any Third Party and its Representatives that has made a <I>bona fide</I> written
Acquisition Proposal that is submitted after the date of this Agreement but prior to the Closing Date to the Boards by such Third Party (and not withdrawn) if: <I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the submission of such Acquisition Proposal shall not have resulted from the breach by the Company or any Representative of
any of the Company or any of its Subsidiaries of the provisions set forth in Section 5.03(a); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(ii) the Boards
reasonably conclude in good faith, after consultation with their outside legal counsel and financial advisor of nationally recognized reputation, that such <I>bona fide</I> written Acquisition Proposal constitutes or would reasonably be expected to
lead to a Superior Proposal; <I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) at least 24 hours prior to furnishing any such information to, or entering into
discussions with, such Third Party (or its Representatives), Parent receives written notice from the Company of the identity of such Third Party and of the Company&#146;s intention to furnish </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
information to, or enter into discussions with, such Third Party, and the Company receives from such Person an executed confidentiality agreement in a customary form that is no less favorable to
the Company (including standstill provisions) than the Confidentiality Agreement and does not contain any provision calling for an exclusive right to negotiate with the Company (an &#147;<B>Acceptable Confidentiality Agreement</B>&#148;) (which the
Company may negotiate with the Third Party during the 24 hour notice period and enter into during such period or thereafter); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the Company provides or makes available all such information to Parent (to the extent that such information has not been
previously provided or made available to Parent) prior to or substantially concurrently with the time it is provided or made available to such Third Party); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Boards determine in good faith, after consultation with outside legal counsel, that the failure to take such action
could be inconsistent with their fiduciary duties under Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, nothing contained herein shall prevent the Company or the Boards
from (i)&nbsp;taking and disclosing to the Company&#146;s shareholders a position contemplated by Rule 14d-9 and Rule 14e-2(a) promulgated under the 1934 Act (or any similar communication to shareholders in connection with the making or amendment of
a tender offer or exchange offer) or from making any legally required disclosure to shareholders with regard to the transactions contemplated by this Agreement or an Acquisition Proposal, (ii)&nbsp;issuing a &#147;stop, look and listen&#148;
disclosure or similar communication of the type contemplated by Rule 14d-9(f) under the 1934 Act or (iii)&nbsp;contacting and engaging in discussions with any person or group and their respective Representatives who has made an Acquisition Proposal
that was not solicited in breach of Section 5.03(a) solely for the purpose of clarifying such Acquisition Proposal and the terms thereof (<I>provided</I> that, in the cases of both clauses (i)&nbsp;and (ii)&nbsp;above, any such disclosure or
communication does not contain an Adverse Recommendation Change unless permitted by Section 5.03(e) or Section 5.03(f)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In addition
to the other obligations of the Company set forth in Section 5.03, the Company shall notify Parent promptly (but in no event later than two Business Days) orally and in writing after receipt by the Company (or any of its Representatives) of any
Acquisition Proposal or any request for non-public information relating to the Company or any of its Subsidiaries or for access to the business, properties, assets, books or records of the Company or any of its Subsidiaries by any Third Party that
has notified the Company that it may be considering making, or has made, an Acquisition Proposal. Each such notice shall include (i)&nbsp;the identity of the Third Party making or submitting such Acquisition Proposal or request, and (ii)&nbsp;a copy
of all written materials provided </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by such Third Party in connection with, and the material terms of, such Acquisition Proposal. After receipt of the Acquisition Proposal or request, the Company shall continue promptly (and in any
event within 24 hours of any material change or development with respect to such Acquisition Proposal) to keep Parent reasonably informed orally or in writing of the status, terms and pertinent details of any such Acquisition Proposal or request
(including by providing prompt notice of all material amendments or proposed material amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Except as expressly
permitted under Section 5.03(e) or Section 5.03(f), none of the Company, the Boards or any committee thereof shall (i)(A) withhold, fail to include in (or remove from) the Schedule 14D-9 or the EGM Materials, withdraw, qualify or modify (or resolve,
determine or publicly propose to withhold, fail to include in (or remove from) the Schedule 14D-9 or the EGM Materials, withdraw, qualify or modify) the Company Recommendation or (B)&nbsp;adopt, approve, recommend, submit to shareholders or declare
advisable (or resolve, determine or publicly propose to adopt, approve, recommend, submit to shareholders or declare advisable) any Acquisition Proposal (any action described in this clause (i)&nbsp;being referred to as an &#147;<B>Adverse
Recommendation Change</B>&#148;) or (ii)&nbsp;adopt, approve, recommend, submit to shareholders or declare advisable (or resolve, determine or publicly propose to adopt, approve, recommend, submit to shareholders or declare advisable), or allow the
Company or any of its Subsidiaries to execute or enter into, any Alternative Acquisition Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in this
Agreement to the contrary, if the Company receives an Acquisition Proposal, other than as a result of breaching or violating Section 5.03(a), that the Boards conclude in good faith, after consultation with their outside legal counsel and financial
advisor of nationally recognized reputation, constitutes a Superior Proposal, the Boards may, at any time prior to the Closing Date, if they determine in good faith, after consultation with their outside legal counsel, that the failure to take such
actions contemplated by clauses (x)&nbsp;and/or (y)&nbsp;below would likely be inconsistent with the Boards&#146; fiduciary duties under Applicable Law, (x)&nbsp;effect an Adverse Recommendation Change with respect to such Superior Proposal and/or
(y)&nbsp;terminate this Agreement pursuant to Section 8.01(d)(i) and simultaneously enter into an Alternative Acquisition Agreement with respect to such Superior Proposal; provided, however, that the Company shall not terminate this Agreement
pursuant to the foregoing clause (y)&nbsp;or Section 8.01(d)(i), and any purported termination pursuant to the foregoing clause (y)&nbsp;or Section 8.01(d)(i) shall be void and of no force or effect, unless in advance of or concurrently with such
termination the Company pays the Termination Fee and otherwise complies with the provisions of Section 8.01(d)(i) and Section 9.04(a)(i); and provided, further, that the Boards may not effect an Adverse Recommendation Change pursuant to the
foregoing clause (x)&nbsp;or terminate this Agreement pursuant to the foregoing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clause (y)&nbsp;or Section 8.01(d)(i) unless: (i)&nbsp;the Company shall have provided prior written notice to Parent, at least five Business Days in advance (the &#147;<B>Superior Proposal
Notice Period</B>&#148;), of its intention to effect such an Adverse Recommendation Change (which notice itself shall not constitute an Adverse Recommendation Change) and/or terminate this Agreement to enter into an Alternative Acquisition Agreement
with respect to such Superior Proposal, which notice shall identify the Third Party or group making such Superior Proposal, and contain the execution draft of the relevant proposed Alternative Acquisition Agreement (which shall include the financial
terms of such Superior Proposal) with the Third Party or group making such Superior Proposal and any other material documents with respect to such Superior Proposal (including any with respect to the financing thereof); and (ii)&nbsp;prior to
effecting such Adverse Recommendation Change and/or terminating this Agreement to enter into an Alternative Acquisition Agreement with respect to such Superior Proposal, (A)&nbsp;if requested by Parent, the Company shall have, and shall have caused
the Company&#146;s Representatives to, during the Superior Proposal Notice Period, negotiate with Parent in good faith to make such adjustments in the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a
Superior Proposal, and (B)&nbsp;Parent shall not have, during the Superior Proposal Notice Period, made a written offer that would, after consideration of such offer by the Boards in good faith and after consultation with their outside legal counsel
and financial advisor of nationally recognized reputation, result in the Boards determining that such Superior Proposal no longer constitutes a Superior Proposal. In the event of any amendment to the financial terms or any other material revisions
to the Superior Proposal after the start of the Superior Proposal Notice Period, the Company shall be required to deliver a new written notice to Parent pursuant to Section 5.03(e)(i) and to comply with the requirements of this Section 5.03(e) with
respect to such new written notice (including a new Superior Proposal Notice Period), except the Superior Proposal Notice Period shall be at least three Business Days (rather than the five Business Days contemplated by Section 5.03(e)(i) above).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding anything to the contrary contained in this Agreement, and solely in response to an Intervening Event, the Boards may
effect an Adverse Recommendation Change prior to the Closing Date if each of the Boards determines in good faith, after consultation with their outside legal counsel and financial advisor of nationally recognized reputation, that the failure to do
so would likely be inconsistent with the directors&#146; fiduciary duties under Applicable Law; provided, however, that the Boards may not effect such an Adverse Recommendation Change unless: (i)&nbsp;the Company shall have provided prior written
notice to Parent, at least five Business Days in advance (the &#147;<B>Intervening Event Notice Period</B>&#148;), of its intention to effect such an Adverse Recommendation Change (which notice itself shall not constitute an Adverse Recommendation
Change), which notice shall specify in reasonable detail such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Intervening Event; and (ii)&nbsp;prior to effecting such Adverse Recommendation Change, (A)&nbsp;if requested by Parent, the Company shall have, and shall have caused the Company&#146;s
Representatives to, during the Intervening Event Notice Period, negotiate with Parent in good faith to make such adjustments in the terms and conditions of this Agreement so that an Adverse Recommendation Change is no longer necessary, and
(B)&nbsp;Parent shall not have, during the Intervening Event Notice Period, made a written offer that that, after due consideration of such offer by the Boards in good faith and after consultation with their outside legal counsel and financial
advisor of nationally recognized reputation, results in both Boards determining that it would not continue to be likely to be inconsistent with the director&#146;s fiduciary duties under Applicable Law to not effect the Adverse Recommendation
Change. In the event of any material changes to the circumstances applicable to the Intervening Event, after the start of the Intervening Event Notice Period, the Company shall be required to deliver a new written notice to Parent pursuant to
Section 5.03(f)(i) and to comply with the requirements of this Section 5.03(f) with respect to such new written notice (including a new Intervening Event Notice Period) except the Intervening Event Notice Period shall be at least three Business Days
(rather than the five Business Days contemplated by Section 5.03(f)(i) above). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Company shall keep confidential any proposals made
by Parent to revise the terms of this Agreement, other than in the event of any amendment to this Agreement and to the extent required by Applicable Law to be disclosed in any Company SEC Documents or otherwise in accordance with the Confidentiality
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) No Adverse Recommendation Change shall change the approval of the Boards for purposes of causing any Anti-Takeover Measure
to be applicable to the transactions contemplated by this Agreement or the Tender Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) For purposes of this Agreement,
&#147;<B>Superior Proposa</B>l&#148; means a <I>bona fide</I>, unsolicited written Acquisition Proposal (that has not been withdrawn and that did not result from a breach of the provisions of Section 5.03(a)) to acquire all of the outstanding Shares
or all or substantially all of the consolidated assets of the Company and its Subsidiaries, which (a)&nbsp;is not subject to a financing condition (and if financing is required, such financing is committed, or is reasonably expected to be committed,
to the Third Party or &#147;group&#148; (as defined in or under Section&nbsp;13(d) of the 1934 Act) making such Acquisition Proposal), (b)&nbsp;is reasonably likely to be consummated on the terms and conditions contemplated thereby, and (c)&nbsp;the
Boards determine in good faith by a majority vote, after considering the advice of a financial advisor of nationally recognized reputation, is on terms more favorable to the Company&#146;s shareholders and other stakeholders than as provided
hereunder, in each case taking into account the various legal, financial and regulatory aspects of the proposal, including the financial and financing terms thereof, the likelihood of consummation in a timely manner, and the identity of the Third
Party or group making such proposal. </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) The Company shall, and shall cause its Subsidiaries and its and their Representatives to,
cease immediately and cause to be terminated any and all existing discussions or negotiations, if any, with any Third Party and its Representatives conducted prior to the date hereof with respect to any Acquisition Proposal or any inquiry or
indication of interest that could reasonably be expected to lead to any Acquisition Proposal. The Company shall promptly (but in no event later than 48 hours following the execution of this Agreement) demand that each Third Party that has heretofore
executed a confidentiality agreement with the Company or any of its Affiliates or Subsidiaries or any of its or their Representatives with respect to such Third Party&#146;s consideration of a possible Acquisition Proposal at any time after
January&nbsp;1, 2014 (other than agreements that have expired by their terms) to immediately return or destroy (which destruction shall subsequently be certified in writing by such Third Party to the Company if such Third Party is required to do so
pursuant to the terms of the non-disclosure or confidentiality agreement between such Third Party and the Company) all confidential information heretofore furnished by the Company, any of its Subsidiaries or any of its or their Affiliates or
Representatives to such Third Party, its Subsidiaries or any of its or their Affiliates or Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04.
<I>Compensation Arrangements</I>. Prior to the Expiration Time, the Company (acting through its Compensation Committee) will take all steps that may be required, necessary or advisable to cause each Company Plan or similar arrangement that has been
or after the date of this Agreement will be entered into by the Company or any of its Subsidiaries with any of its directors, officers or employees pursuant to which consideration is payable to any director, officer or employee to be approved by the
Compensation Committee as an &#147;employment compensation, severance or other employee benefit arrangement&#148; within the meaning of Rule 14d-10(d)(2) under the 1934 Act and to satisfy the requirements of the non-exclusive safe harbor set forth
in Rule 14d-10(d) of the 1934 Act. At the time of the taking of such steps described in this Section&nbsp;5.04, the Compensation Committee will be composed solely of &#147;independent directors&#148; within the meaning of Rule 14d-10(d)(2) under the
Exchange Act and the instructions thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05. <I>Anti-Takeover Measures</I>. The Company and the Boards shall take all
actions within their power and authority necessary so that the restrictions of any Anti-Takeover Measures do not prevent or materially delay any and all of the transactions contemplated by this Agreement. If any Anti-Takeover Measure becomes
applicable to any of the transactions contemplated by this Agreement and the Tender Agreements, to the extent reasonably possible, the Company and the Boards shall grant such approvals and take such actions within their power and authority as are
necessary, so that any such transactions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contemplated by this Agreement and the Tender Agreements may be consummated as promptly as practicable on the terms contemplated by this Agreement or the Tender Agreement, as applicable, and
otherwise act within their power and authority to eliminate or minimize the effects of such Anti-Takeover Measures on such transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06. <I>Innovation Box</I>. Prior to the Closing, the Company shall, and shall cause its Subsidiaries to: (i)&nbsp;provide
Parent with a copy of any correspondence, written information or other document received from a Taxing Authority (or, in the case of oral communications, a summary of such communication) that relates to the Innovation Box (<I>innovatiebox</I>) (the
&#147;<B>Innovation Box</B>&#148;) and/or net operating loss carryforwards (<I>verrekenbare verliezen</I>) for Dutch Tax purposes promptly upon receipt of such correspondence, information, report or communication, (ii)&nbsp;reasonably consider any
such actions with respect to the Innovation Box as the Parent may reasonably request, (iii)&nbsp;provide Parent an opportunity to review, consult and comment on any correspondence or other documents to be sent to a Taxing Authority to the extent
they relate to the Innovation Box and/or net operating loss carryforwards reasonably prior to, and to the extent practicable, no later than seven days prior to, the date that such response will be, or is required to be, sent to the Taxing Authority,
(iv)&nbsp;consider in good faith comments received from Parent with respect to any such correspondence or other documents, and (v)&nbsp;not initiate or enter into any discussions with a Taxing Authority relating to the Innovation Box without
providing Parent with reasonable prior written notice of such discussions, to the extent practicable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 6 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> P<SMALL>ARENT</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parent agrees that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01. <I>Conduct of Parent</I>. Parent shall not, and shall cause its Subsidiaries not to, from the date of this Agreement to the
Closing, take any action or fail to take any action that is intended to, or would reasonably be expected to, individually or in the aggregate, prevent, materially delay or materially impede the ability of Parent and Buyer to consummate the Offer or
the other transactions contemplated by this Agreement, including the financing thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02. <I>Obligations of Buyer</I>.
Parent shall take all action necessary to cause Buyer to perform its obligations under this Agreement and to consummate the Offer on the terms and conditions set forth in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03. <I>Director and Officer Liability</I>. Parent shall cause Buyer and the
Company to do the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) For six years after the Closing, Buyer and the Company shall indemnify and hold harmless the
present and former directors, officers or employees of the Company and its Subsidiaries (each, an &#147;<B>Indemnified Person</B>&#148;) in respect of acts or omissions occurring at or prior to the Closing to the fullest extent permitted by
Applicable Law or provided under the Company&#146;s organizational documents in effect on the date hereof. In the event that any Indemnified Person is made party to any Action arising out of or relating to matters that would be indemnifiable
pursuant to the immediately preceding sentence, Buyer and the Company shall advance fees, costs and expenses (including reasonable attorney&#146;s fees and disbursements) as incurred by such Indemnified Person in connection with and prior to the
final disposition of such Action, subject to the execution by such Indemnified Person of appropriate undertakings to repay such advanced fees, costs and expenses if it is ultimately determine that such Indemnified Person is not entitled to
indemnification.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) For six years after the Closing, Buyer and the Company shall maintain in effect provisions in the
Company&#146;s organizational documents (or in such documents of any successor to the business of the Company&#146;s) regarding exculpation of liability of directors, indemnification of directors, officers and employees and advancement of fees,
costs and expenses that are no less advantageous to the intended beneficiaries than the corresponding provisions in existence on the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Prior to the Closing, the Company shall or, if the Company is unable to, Parent shall cause Company after the Closing to, obtain and fully
pay the premium for the non-cancellable extension of the directors&#146; and officers&#146; liability coverage of the Company&#146;s existing directors&#146; and officers&#146; insurance policies and the Company&#146;s existing fiduciary liability
insurance policies (collectively, &#147;<B>D&amp;O Insurance</B>&#148;), in each case for a claims reporting or discovery period of at least six years from and after the Closing with respect to any claim related to any period of time at or prior to
the Closing from an insurance carrier with the same or better credit rating as the Company&#146;s current insurance carrier with respect to D&amp;O Insurance with terms, conditions, retentions and limits of liability that are no less favorable than
the coverage provided under the Company&#146;s existing policies with respect to any actual or alleged error, misstatement, misleading statement, act, omission, neglect, breach of duty or any matter claimed against a director or officer of the
Company or any of its Subsidiaries by reason of him or her serving in such capacity that existed or occurred at or prior to the Closing (including in connection with this Agreement or the transactions or actions contemplated hereby). If the Company
for any reason fail to obtain such &#147;tail&#148; insurance policies as of the Closing, Parent shall cause Buyer or the Company to continue to maintain in effect, for a period of at least six years from and after the Closing, the D&amp;O Insurance
in place as of the date hereof with the Company&#146;s current insurance carrier or with an insurance carrier with the same or better credit rating as the Company&#146;s current insurance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
carrier with respect to D&amp;O Insurance with terms, conditions, retentions and limits of liability that are no less favorable than the coverage provided under the Company&#146;s existing
policies as of the date hereof, or Buyer shall purchase from the Company&#146;s current insurance carrier or from an insurance carrier with the same or better credit rating as the Company&#146;s current insurance carrier with respect to D&amp;O
Insurance comparable D&amp;O Insurance for such six-year period with terms, conditions, retentions and limits of liability that are no less favorable than as provided in the Company&#146;s existing policies as of the date hereof. In no event shall
Parent be required to, and the Company shall not, expend for such policies pursuant to the previous sentence an annual premium amount in excess of 300% of the amount per annum the Company paid in its last full fiscal year (it being agreed that if
the aggregate premiums of such insurance coverage exceed such amount, the Company shall be obligated to obtain a policy with the greatest coverage available, with respect to matters occurring prior to the Closing, for a cost not exceeding such
amount). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If Buyer, the Company or any of its successors or assigns (i)&nbsp;consolidates with or merges into any other Person and
shall not be the continuing or surviving corporation or entity of such consolidation or merger, or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, to the extent
necessary, proper provision shall be made so that the successors and assigns of Buyer or the Company, as the case may be, shall assume the obligations set forth in this Section 6.03. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The rights of each Indemnified Person under this Section 6.03 shall be in addition to any rights such Person may have under the
organizational documents of the Company or any of its Subsidiaries, under Applicable Law or under any agreement of any Indemnified Person with the Company or any of its Subsidiaries. These rights shall survive consummation of the transactions
contemplated hereby and are intended to benefit, and shall be enforceable by, each Indemnified Person. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;6.04<I>.
Employee Matters. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(a) For a period commencing on the Closing and ending on the first anniversary of the Closing (or, such
shorter period of employment, as the case may be), each employee who remains employed by Parent, Buyer or any of their respective Subsidiaries (each, a &#147;<I></I><B>Continuing Employee</B><I></I>&#148;) shall receive from Parent or Buyer
(i)&nbsp;an annual rate of salary or wages that is no less favorable than the annual rate of salary or wages provided to such Continuing Employee by the Company and its Subsidiaries as of immediately prior to the Closing (<I>provided</I>, that, any
increase in such salary or wages following the date hereof was made in compliance with Section 5.01(j)), (ii)&nbsp;bonus opportunities and employee benefits that are no less favorable than the bonus opportunities or employee benefits, as applicable,
provided to such Continuing Employee by the Company and its <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
</I>Subsidiaries as of immediately prior to the Closing (<I>provided</I>, that, any increase in such bonus opportunities or employee benefits following the date hereof was made in compliance with
Section 5.01(j)) and (iii)&nbsp;severance benefits that are no less favorable than the severance benefits for which such Continuing Employee was eligible immediately prior to the Closing (<I>provided</I>, that, any increase in such severance
benefits following the date hereof was made in compliance with Section 5.01(j)), <I>provided</I> that, upon a qualifying termination of employment, such severance benefits shall in no event be less than six months of the annual rate of salary or
wages provided to such Continuing Employee by the Company and its Subsidiaries as of immediately prior to the Expiration Time.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
As of the Closing and solely with respect to Continuing Employees, should Parent elect to transition a Continuing Employee from a Company Plan to a welfare plan of Parent or Buyer, Parent shall cause Buyer, and any of their respective Subsidiaries
or any of their respective third party insurance providers or third party administrators to, waive all limitations as to any pre-existing condition or waiting periods in its applicable welfare plans with respect to participation and coverage
requirements applicable to each Continuing Employee under any welfare plans that such Continuing Employees may be eligible to participate in after the Closing and to credit each Continuing Employee for any copayments, deductibles, offsets or similar
payments made under a Company Plan during the plan year that includes the Closing Date for purposes of satisfying any applicable copayment, deductible, offset or similar requirements under the comparable plans of Parent, Buyer or any of their
respective Subsidiaries. In addition, as of the Closing, Parent shall, and shall cause Buyer and any applicable Subsidiary to, give Continuing Employees full credit for purposes of eligibility, vesting, participation in and determination of level of
benefits under any employee benefit and compensation plans or arrangements (other than with respect to defined benefit plans) maintained by Parent, Buyer or an applicable Subsidiary that such Continuing Employees may be eligible to participate in
after the Closing for such Continuing Employees&#146; service with the Company or any of its Subsidiaries to the same extent that such service was credited for purposes of any comparable Company Plan immediately prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the generality of Section 9.07, the provisions of this Section&nbsp;6.04 are solely for the benefit of the parties to this
Agreement, and no current or former Company Service Provider or any other individual associated therewith shall be regarded for any purpose as a third-party beneficiary of this Section&nbsp;6.04. In no event shall the terms of this Agreement be
deemed to confer upon any Company Service Provider any right to continued employment with Parent or any of its Affiliates (including, following the Closing Date, the Company). Nothing herein shall be deemed to establish, amend, modify or cause to be
adopted any Company Plan or any other benefit plan, program, agreement or arrangement maintained or sponsored by Parent, Buyer, the Company or any of their respective Affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.05. <I>CVRs</I>. At or prior to the Closing, Parent shall cause the CVR Agreement
to be duly authorized, executed and delivered by Parent and the Rights Agent; <I>provided</I>, that Parent may agree to reasonable modifications to the CVR Agreement as requested by the Rights Agent prior to executing the CVR Agreement so long as
such modifications are not adverse to the Holders (as defined in the CVR Agreement) thereunder in any material respect. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 7
</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> P<SMALL>ARENT</SMALL> <SMALL>AND</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties hereto agree that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01. <I>Regulatory Undertakings</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, the Company and Parent shall use reasonable best efforts to take, or cause to be
taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the transactions contemplated by this Agreement, including (i)&nbsp;preparing and filing as promptly as practicable with
any Governmental Authority or other third party all documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of information, applications and other documents and (ii)&nbsp;obtaining and maintaining
all approvals, consents, registrations, permits, authorizations and other confirmations required to be obtained from any Governmental Authority or other third party that are necessary, proper or advisable to consummate the transactions contemplated
by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In furtherance and not in limitation of the foregoing, each of Parent and the Company shall make an appropriate
filing of a Notification and Report Form pursuant to the HSR Act with respect to the transactions contemplated hereby with the United States Federal Trade Commission (the &#147;<B>FTC</B>&#148;) and the Antitrust Division of the United States
Department of Justice (the &#147;<B>Antitrust Division</B>&#148;) as promptly as practicable and in any event within 10 Business Days of the date hereof. Each of Parent and the Company shall (i)&nbsp;respond as promptly as practicable to any
inquiries received from the FTC or the Antitrust Division for additional information or documentation and to all inquiries and requests received from any State Attorney General or other Governmental Authority in connection with antitrust matters,
and (ii)&nbsp;not extend any waiting period under the HSR Act or enter into any agreement with the FTC or the Antitrust Division not to consummate the transactions contemplated by this Agreement, except with the prior written consent of the other
parties hereto. At the request of Parent, the Company shall agree to divest, hold separate or otherwise take or commit to take any action that limits its freedom of action with respect to, or its ability to retain, any of the businesses, services,
or assets of the Company or any of its Subsidiaries (but, absent such request, the Company shall not take any such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
action), provided that any such action shall be conditioned upon the consummation of the Offer and the other transactions contemplated hereby. Each party shall (i)&nbsp;promptly notify the other
party of any written communication to that party from the FTC, the Antitrust Division, any State Attorney General or any other Governmental Authority and, subject to Applicable Law, permit the other party to review in advance any proposed written
communication to any of the foregoing; (ii)&nbsp;to the extent practicable, not agree to participate in any substantive meeting or discussion with any Governmental Authority in respect of any filings, investigation or inquiry concerning any
competition or antitrust matters in connection with this Agreement or the Offer and the other transactions contemplated hereby unless it consults with the other party in advance and, to the extent permitted by such Governmental Authority, gives the
other party the opportunity to attend and participate thereat; and (iii)&nbsp;furnish the other party with copies of all correspondence, filings, and communications (and memoranda setting forth the substance thereof) between them and their
affiliates and their respective Representatives on the one hand, and any government or regulatory authority or members or their respective staffs on the other hand, with respect to any competition or antitrust matters in connection with this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company will, and will cause its Affiliates and their respective Representatives to, consult with and consider in good
faith the views of Parent in connection with any material analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of the Company in connection with any meeting, communication or
filing with the FDA or any corollary entity in any other jurisdiction. The Company shall notify Parent of any material communications with the FDA or any corollary entity in any other jurisdiction relating to the Key Products, whether written or
oral, as soon as reasonably practicable, and the Company shall provide Parent with copies of any such written communications. To the extent practicable, the Company shall not agree to participate in any substantive meeting or discussion with the FDA
or any corollary entity in any other jurisdiction unless it consults with Parent in advance and, to the extent permitted by the FDA or any corollary entity in any other jurisdiction and Applicable Law, gives Parent the opportunity to attend and
participate thereat. The Company shall furnish Parent with copies of all material correspondence, filings, and communications between the Company and its Affiliates and their respective Representatives, on the one hand, and the FDA or any corollary
entity in any other jurisdiction or their respective staffs, on the other hand. From time to time and at the reasonable request of Parent, the Company shall provide Parent with updates concerning the progress of the Company&#146;s regulatory filings
and strategy for obtaining necessary regulatory Approvals to market and sell the Key Products. Except to the extent required by Applicable Law or any listing agreement with or rule of any national securities exchange, the Company shall consult with
Parent prior to making any public statement or issuing any press release regarding the status of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regulatory filings concerning the Key Products with the FDA or any corollary entity in any other jurisdiction. Notwithstanding the foregoing provisions in this Section 7.01(c), the Company shall
maintain sole authority over its business decisions and communications prior to the Closing, and the Company&#146;s obligations under this Section 7.01(c) shall be subject to Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;7.02. <I>Certain Filings</I>. The Company and Parent shall cooperate with one another (i)&nbsp;in connection with the
preparation of the Company Disclosure Documents, the Schedule TO and the Offer Documents, (ii)&nbsp;in determining whether any action by or in respect of, or filing with, any Governmental Authority is required, or any actions, consents, approvals or
waivers are required to be obtained from parties to any material contracts, in connection with the consummation of the transactions contemplated by this Agreement and the CVR Agreement and (iii)&nbsp;in taking such actions or making any such
filings, furnishing information required in connection therewith or with the Company Disclosure Documents, the Schedule TO or the Offer Documents and seeking timely to obtain any such actions, consents, approvals or waivers.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;7.03. <I>Further Assurances</I>. The Company and Parent shall cooperate with one another and use their respective
reasonable best efforts to cause the Pre-Launch Condition to be satisfied; <I><U>provided</U></I> that neither Parent nor Buyer shall be obligated to modify any of their respective obligations with respect to matters occurring following the Closing
Date, in each case in any respect that is material to the specific obligation requested to be modified, or be required to make any material commitments to the works council and/or employee representative bodies. The Company shall use commercially
reasonable efforts to provide Parent, the Buyer and their counsel with any comments or other communications, whether written or oral, that the Company or its counsel may receive from time to time from the Company&#146;s works council and/or employee
representative bodies related to the satisfaction of the Pre-Launch Condition. The Company will provide Parent and the Buyer with an opportunity to review and comment on any materials to be provided to the works council and/or employee
representative bodies and will consider their comments in good faith. Each of Parent and Buyer shall provide such information as may be reasonably be requested by the Company and the Works Council relating to the Pre-Launch Condition. <I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;7.04. <I>Public Announcements</I>. The initial press release relating to this Agreement shall be a joint press release
issued by the Company and Parent and thereafter Parent and the Company shall consult with the other before issuing any press release or otherwise making any public statement with respect to the Offer. Notwithstanding the foregoing, (a)&nbsp;each
party may, without complying with the foregoing obligations, make any public statement in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to employees and make
disclosures in <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
documents filed or furnished to the SEC, to the extent that such statements are consistent with previous press releases, public disclosures or public statements made jointly by the parties and
otherwise in compliance with this Section 7.04, (b)&nbsp;a party may, without complying with the foregoing obligations, issue any press release or make any public statement as may be required by Applicable Law or any listing agreement with or rule
of any national securities exchange, (c)&nbsp;the Company need not comply with the foregoing obligations in connection with any press release, public statement or filing to be issued or made with respect to any Adverse Recommendation Change made in
accordance with the terms of Section&nbsp;5.03(e) or Section&nbsp;5.03(f); <I>provided</I>, <I>however</I>, that upon issuing or making, as applicable, any such release, statement or filing as provided in clause (b)&nbsp;or (c)&nbsp;above, the
Company shall, as soon as reasonably practicable thereafter, give Parent notice of and a written copy of such press release, public statement or filing; and (d)&nbsp;Parent need not comply with the foregoing obligations in connection with any press
release, public statement or filing to be issued or made in connection with any matter described in clause (c)&nbsp;above or any actions taken or to be taken in connection therewith, provided that, Parent shall, as soon as reasonably practicable
thereafter, give the Company notice of and a written copy of such release, announcement or statement<I>.</I> The Company may not hold any analyst calls or other publicly attended conference calls in connection with the execution and delivery of this
Agreement and the announcement of the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;7.05<I>. Notices of Certain Events. </I>Each
of the Company and Parent shall promptly notify the other of:<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) any written notice or other written communication from any
Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) any written notice or other written communication from any Governmental Authority in connection with the transactions contemplated by this
Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the occurrence or non-occurrence of any change, condition or event (i)&nbsp;that has had or is reasonably likely to have a
Company Material Adverse Effect or Parent Material Adverse Effect, as applicable, or (ii)&nbsp;that would result in the nonfulfillment of any of the conditions to Parent&#146;s obligations hereunder; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) any Actions commenced or, to its knowledge, threatened in writing against, relating to or involving or otherwise affecting the Company or
any of its Subsidiaries or Parent and any of its Subsidiaries, as the case may be, that that relate to the consummation of the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No such notice, nor any information obtained therefrom, shall be deemed to cure any breach of any
representation, warranty or covenant made in this Agreement or have any effect for purposes of determining satisfaction of the conditions set forth in this Agreement, or the compliance with any covenant set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;7.06<I>. Litigation and Proceedings</I>. The Company shall control the defense and/or settlement of any Action against the
Company or any of its directors relating to this Agreement, the Offer or the other transactions contemplated by this Agreement; <I>provided</I> that the Company shall give Parent reasonable opportunity to participate, at Parent&#146;s expense, in
such Action, including (a)&nbsp;keeping Parent reasonably apprised of proposed strategies and other material decisions with respect to such Action (to the extent that attorney-client privileged between the Company and its counsel is not breached)
and (b)&nbsp;affording Parent a reasonable opportunity to review and comment on all material filings or responses to be made by the Company in connection with such Action, and in good faith take any such comments into account; <I>provided</I>,
<I>further</I>, that the Company agrees that it shall not settle any such Action without the prior written consent of Parent, which shall not be unreasonably withheld, delayed or conditioned, except no settlement shall be effected unless Parent has
provided its written consent, which may be withheld in its sole discretion, if the settlement (i)&nbsp;does not include a full and unconditional release of the Company, Parent, Buyer and their respective Affiliates (to the extent that any such
Person is a defendant in such Action) or (ii)&nbsp;exceeds the limits of liability coverage provided for in the D&amp;O Insurance. <I> </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 8</U></B><U>.<B></B></U><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">T<SMALL>ERMINATION</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.01. <I>Termination</I>. This Agreement may be terminated at any time prior to the Closing:<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) by mutual written agreement of the Company and Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) by either the Company or Parent, if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(i) the Closing shall not have occurred on or before April&nbsp;30, 2015 (the &#147;<B>End Date</B>&#148;);
<B></B><I>provided</I><B></B> that the right to terminate this Agreement pursuant to this Section 8.01(b)(i) shall not be available to any party whose breach of any provision of this Agreement results in the failure of the Closing to be consummated
by such time; <B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) there shall be any Applicable Law or permanent injunction or other order issued by a court of
competent jurisdiction permanently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
restraining, making illegal or otherwise prohibiting consummation of the Offer or the Asset Sale and such injunction or other order shall have become final and non-appealable; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(iii) the Offer shall have expired without all of the Offer Conditions having been satisfied and shall have not been
extended by Buyer; <I>provided</I> that the right to terminate this Agreement pursuant to this Section 8.01(b)(iii) shall not be available to any party whose breach of any provision of this Agreement results in the Offer having expired without all
of the Offer Conditions having been satisfied; <I>provided</I>, <I>further</I>, that the right to terminate this Agreement pursuant to Section 8.01(b)(iii) shall not be available to Parent if Parent has not caused Buyer to extend the Offer in
circumstances where Buyer is required to extend the Offer under this Agreement;<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) by Parent, if, prior to the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(i) (A) if the Boards (or any committee thereof) shall have effectuated an Adverse Recommendation Change (whether or not
in compliance with Section&nbsp;5.03), (B)&nbsp;the Company fails to issue a press release that expressly reaffirms the Company Recommendation within five Business Days after the Company&#146;s receipt of a written request by Parent to provide such
reaffirmation (or if the End Date is less than five (but more than two) Business Days from receipt of such request from Parent, by the close of business on the penultimate Business Day preceding the End Date) following the date that any Third Party
or group (as defined under Section&nbsp;13(d) of the 1934 Act), other than Parent or Buyer, (x)&nbsp;shall have made an Acquisition Proposal (other than a tender offer or exchange offer described in clause (C)&nbsp;below) and the existence of such
Acquisition Proposal becomes publicly known (and not publicly withdrawn) or (y)&nbsp;shall have publicly announced an intention (whether or not conditional) (and not publicly withdrawn such intention) to make an Acquisition Proposal or the existence
of an intention to make an Acquisition Proposal shall have otherwise become publicly known (<I><U>provided</U></I> that Parent may only request such reaffirmation once for any Acquisition Proposal or any material change thereto), (C)&nbsp;any tender
offer or exchange offer that constitutes an Acquisition Proposal is commenced (and not withdrawn), and the Boards shall not have recommended that the Company&#146;s shareholders reject such tender offer or exchange offer and not tender their Shares
into such tender offer or exchange offer within ten Business Days after commencement of such tender offer or exchange offer or (D)&nbsp;the Company shall have breached Section&nbsp;5.03 in any material respect (other than inadvertent breaches);
or<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(ii) a breach of any representation or warranty or failure to perform any
covenant or agreement on the part of the Company set forth in this Agreement shall have occurred that would cause the conditions set forth in clauses (D)&nbsp;or (E)&nbsp;of Part 2 of Annex I to fail to be satisfied and is incapable of being cured
by the End Date or, if curable, is not cured by the Company by the earlier of (x)&nbsp;30 days after receipt by the Company of written notice of such breach or failure and (y)&nbsp;the expiration of the Offer; <I>provided</I> that, at the time at
which Parent or Buyer would otherwise exercise such termination right, Parent and Buyer shall not be in material breach of its or their obligations under this Agreement;<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) by the Company if, prior to the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(i) the Boards authorize the Company to enter into an Alternative Acquisition Agreement concerning a Superior Proposal,
but only if the Company is permitted to accept such Superior Proposal pursuant to Section 5.03(e); <I>provided</I> that concurrently with such termination, the Company enters into the Alternative Acquisition Agreement and pays the Termination Fee
payable pursuant to Section 9.04(a)(i); <I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(ii) a breach in any material respect of any representation or
warranty or failure to perform any covenant or agreement on the part of Parent or Buyer set forth in this Agreement shall have occurred that (A)&nbsp;has or would reasonably be expected to have a Parent Material Adverse Effect and (B)&nbsp;is
incapable of being cured by the End Date or, if curable, is not cured by Parent or Buyer by the earlier of (x)&nbsp;30 days after receipt by the Company of written notice of such breach or failure and (y)&nbsp;the expiration of the Offer;
<I>provided</I> that, at the time at which the Company would otherwise exercise such termination right, the Company shall not be in material breach of its obligations under this Agreement; or<I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) (A) (x)Buyer shall not have commenced the Offer within the later of (1)&nbsp;fifteen Business Days following the date
hereof or (2)&nbsp;five Business Days following satisfaction or waiver of the Pre-Launch Condition or (y)&nbsp;the Offer shall have expired and not been extended by Buyer, and Buyer, in violation of this Agreement, fails to accept for payment within
three Business Days following expiration all Shares validly tendered and not validly withdrawn pursuant to the Offer, and (B)&nbsp;Buyer has not cured such failure within five Business Days after receipt by the Company of written notice of such
failure; <I>provided</I> that the Company may not terminate this agreement under Section&nbsp;8.03(c)(iii)(A) if Buyer&#146;s failure to commence the Offer within the later of five Business Days following satisfaction or waiver of the Pre-Launch
Condition or fifteen Business Days following the date of this Agreement, as applicable, results from the Company&#146;s breach of any provision of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The party desiring to terminate this Agreement pursuant to this Article 8 (other than pursuant to Section
8.01(a)) shall give notice of such termination to the other party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.02. <I>Effect of Termination. </I>If this
Agreement is terminated pursuant to Article 8, this Agreement shall become void and of no effect without liability of any party (or any shareholder, director, officer, employee, agent, consultant or representative of such party) to the other party
hereto; <I>provided</I> that, if such termination shall result from the intentional (i)&nbsp;failure of either party to fulfill a condition to the performance of the obligations of the other party or (ii)&nbsp;failure of either party to perform a
covenant hereof, such party shall be fully liable for any and all liabilities and damages (which the parties acknowledge and agree shall not be limited to reimbursement of expenses or out-of-pocket costs, and may include the benefit of the bargain
lost by a party or a party&#146;s shareholders, which shall be deemed in such event to be damages of such party) incurred or suffered by the other party as a result of such failure. The provisions of this Section 8.02 and Sections 9.01, 9.04, 9.05,
9.08, 9.09, 9.10 and 9.13 shall survive any termination hereof pursuant to Article 8.<I> </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 9 </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">M<SMALL>ISCELLANEOUS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.01. <I>Notices</I>. All notices, requests and other communications to any party hereunder (each, a
&#147;<I></I><B>Notice</B><I></I>&#148;) shall be in writing. Such Notice shall be deemed to have been given as of the date delivered to the following: <I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to Parent or Buyer, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">BioMarin Pharmaceutical Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">105 Digital Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novato, CA 94949 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Chief Executive Officer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy, which shall not constitute notice, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">BioMarin Pharmaceutical Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">105 Digital Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novato, CA 94949 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to the Company, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prosensa Holding N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">J.H. Oortweg 21 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2333 CH Leiden </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Netherlands </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Berndt Modig </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies, which shall not constitute notice, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Davis Polk&nbsp;&amp; Wardwell LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">450 Lexington Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, New York 10017 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Michael Davis </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Facsimile No.: (212)&nbsp;701-5800 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">E-mail: michael.davis@davispolk.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">De Brauw Blackstone Westbroek N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Claude Debussylaan 80 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">1082 MD Amsterdam </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Netherlands </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Paul Cronheim </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Facsimile No.: +31205771775 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">E-mail: Paul.Cronheim@debrauw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address or facsimile number as such party may hereafter specify for the purpose by notice to the other parties hereto. All such Notices shall
refer specifically to this Agreement and shall be deemed given only if delivered by FedEx or by other internationally recognized overnight delivery service that maintains records of delivery, addressed to the Parties at their respective addresses
specified in this Section&nbsp;9.01 or to such other address as the Party to whom notice is to be given may have provided to the other Party at least five days&#146; prior to such address taking effect in accordance with this Section&nbsp;9.01. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.02. <I>Survival of Representations and Warranties</I>. The representations
and warranties contained herein and in any certificate or other writing delivered pursuant hereto shall not survive the Closing.<I> </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03. <I>Amendments and Waivers.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Any provision of this Agreement may be amended or waived prior to the Closing if, but only if, such amendment or waiver is in writing and
is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the waiver is to be effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any
single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies
provided by Applicable Law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.04. <I>Expenses.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>General</U>. Except as otherwise provided herein, all costs and expenses incurred in connection with this Agreement shall be paid by the
party incurring such cost or expense. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Termination Fee</U>. If this Agreement is terminated by Parent pursuant to
Section 8.01(c)(i) or by the Company pursuant to Section 8.01(d)(i), then the Company shall pay to Parent by wire transfer of immediately available funds $23,800,000 (the &#147;<B>Termination Fee</B>&#148;), in the case of a termination by Parent,
within one Business Day after such termination and, in the case of a termination by the Company, immediately before and as a condition to such termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(ii) If (A)&nbsp;this Agreement is terminated by Parent or the Company pursuant to Section 8.01(b)(i), Section
8.01(b)(iii) or Section 8.01(c)(ii), but in the case of termination pursuant to Section 8.01(c)(ii) only in the case of an intentional and material breach by the Company of its obligations hereunder, (B)&nbsp;after the date of this Agreement and
prior to such termination, an Acquisition Proposal shall have been made known to the Company or publicly disclosed or announced (and not publicly withdrawn prior to such termination), and (C)&nbsp;within 12 months following the date of such
termination, the Company enters into a definitive agreement to consummate an Acquisition Proposal or consummates an Acquisition Proposal (regardless of whether such Acquisition proposal is the same Acquisition Proposal referred to in clause (B))
(<I>provided</I> that for purposes of this clause (C), each reference to &#147;20%&#148; in the definition of <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Acquisition Proposal shall be deemed to be a reference to &#147;50%&#148;), then the Company shall pay to Parent by wire transfer of immediately available funds, concurrently with the earlier of
the Company&#146;s entry into such definitive agreement or the consummation of such Acquisition Proposal, the Termination Fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each
of the Company, Parent and Buyer acknowledges that (i)&nbsp;the agreements contained in this Section&nbsp;9.04 are an integral part of the transactions contemplated by this Agreement, (ii)&nbsp;without these agreements, Parent, Buyer and the Company
would not enter into this Agreement and (iii)&nbsp;the Termination Fee is not a penalty, but rather constitutes damages in a reasonable amount that will reasonably compensate Parent and Buyer in the circumstances in which such Termination Fee is
payable. In the event that the Company shall fail to pay the Termination Fee when due, the Company shall reimburse Parent and Buyer for all reasonable costs and expenses actually incurred or accrued by them (including reasonable fees and expenses of
counsel) in connection with the collection under and enforcement of this Section&nbsp;9.04, together with interest on the Termination Fee at the prime rate as quoted on Bloomberg screen (PRIMBB Index) in effect on the date such payment was required
to be made through the date of payment plus 2%&nbsp;per annum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Parent and Buyer agree that, upon any termination of this Agreement
under circumstances where the Termination Fee is payable by the Company pursuant to this Section and such Termination Fee is paid in full, Parent and Buyer shall be precluded from any other remedy against the Company, at law or in equity or
otherwise, and neither Parent nor Buyer shall seek to obtain any recovery, judgment, or damages of any kind, including consequential, indirect, or punitive damages, against the Company or any of the Company&#146;s Subsidiaries or any of their
respective directors, officers, employees, partners, managers, members, shareholders or Affiliates or their respective Representatives in connection with this Agreement, the Tender Agreements, the CVR Agreement or the transactions contemplated
hereby or thereby. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.05. <I>Investment.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(a) Within five Business Days following the execution of this Agreement, the Company shall issue and sell to the Buyer, and Buyer shall
purchase from the Company, a convertible promissory note (the &#147;<B>Promissory Note</B>&#148;) in the principal amount of &#128;40,355,125.10, in the form mutually agreed between the parties on the date hereof. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>(b) From and after the date of this Agreement except as provided in Section 9.05(c) below, Buyer will not (i)&nbsp;transfer, assign or
dispose of (&#147;<B>Transfer</B>&#148;) any or all of the shares issuable upon conversion of the Promissory Note (the &#147;<B>Conversion Shares</B>&#148;), the Promissory Note or any interest therein <B>
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
without the prior written consent of the Company without the consent of the Company, unless permitted by the express terms of the Promissory Note, (ii)&nbsp;enter into any contract, option or
other agreement with respect to any Transfer of any or all Conversion Shares, the Promissory Note or any interest therein without the consent of the Company, unless permitted by the express terms of the Promissory Note, (iii)&nbsp;grant any proxy,
power-of-attorney or other authorization or consent in or with respect to any or all of the Conversion Shares inconsistent with Buyer&#146;s voting obligations hereunder or (iv)&nbsp;deposit any or all of the Conversion Shares into a voting trust or
enter into a voting agreement or arrangement with respect to any or all of the Conversion Shares inconsistent with Buyer&#146;s voting obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(c) If this Agreement is terminated by the Company pursuant to Section 8.01(d)(i) and the Buyer has received the Termination Fee, the
Promissory Note will automatically convert in accordance with its terms and Buyer will vote the Conversion Shares in favor of the transactions contemplated by the Alternative Acquisition Agreement at any meeting of the Shareholders of the Company in
favor of which this Agreement was terminated, and, if applicable, will tender (and not withdraw) the Conversion Shares promptly, and in any event no later than ten Business Days, following the commencement of any tender offer pursuant to such
Alternative Acquisition Agreement. If this Agreement is terminated pursuant to any other provision in Section 8.01, the Promissory Note will automatically convert in accordance with its terms and from and after such termination, Buyer may Transfer
the Conversion Shares in compliance with Applicable Laws; <I>provided</I> Buyer shall not Transfer (other than to Affiliates that expressly agree to be bound by this Section&nbsp;9.05(c)) more than 10% of the daily trading volume of the
Company&#146;s Shares on NASDAQ.<I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06. <I>Disclosure Schedule and SEC Document References.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The parties hereto agree that any reference in a particular Section of the Company Disclosure Schedule shall only be deemed to be an
exception to (or, as applicable, a disclosure for purposes of) (i)&nbsp;the representations and warranties (or covenants, as applicable) of the relevant party that are contained in the corresponding Section of this Agreement and (ii)&nbsp;any other
representations and warranties of such party that is contained in this Agreement, but only if the relevance of that reference as an exception to (or a disclosure for purposes of) such representations and warranties is reasonably apparent. The mere
inclusion of an item in the Company Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission that such item represents a material exception or material fact, event or circumstance or that such item has had
or would reasonably be expected to have a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Subject to the lead-in paragraph of Article 3, the parties hereto agree that any information
contained in any part of any Company SEC Document shall only be deemed to be an exception to (or a disclosure for purposes of) the Company&#146;s representations and warranties if the relevance of that information as an exception to (or a disclosure
for purposes of) such representations and warranties is reasonably apparent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.07. <I>Binding Effect; Benefit;
Assignment.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The provisions of this Agreement shall be binding upon and, except as provided in Section 6.03, shall inure to the
benefit of the parties hereto and their respective successors and assigns. Except as provided in Section 6.03, no provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any Person
other than the parties hereto and their respective successors and assigns and other than the right of any holders of Shares (including Company Restricted Shares) that are not tendered in the Offer or in the Subsequent Offering Period to receive the
Offer Consideration in respect of those Shares or any holders of Company Options to receive the applicable consideration in respect of their Company Options, in each case, as contemplated by Article 2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(b) No party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of
each other party hereto, provided that each of Parent and Buyer shall be permitted to assign all or any portion of its rights and obligations under this Agreement to an Affiliate of Parent without the Company&#146;s consent; <I>provided</I>,
<I>further</I>, that no such assignment shall (i)&nbsp;relieve the assigning party of its obligations under this Agreement or (ii)&nbsp;be permitted if such assignment would reasonably be expected to prevent, impair or materially delay the
consummation of the Offer.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.08. <I>Governing Law</I>. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York, without regard to the conflicts of law rules of such state.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.09. <I>Jurisdiction. </I>The parties hereto agree that any Action seeking to enforce any provision of, or based on any
matter arising out of or in connection with, this Agreement or the transactions contemplated hereby (whether brought by any party or any of its Affiliates or against any party or any of its Affiliates) shall be brought in any state or United States
federal court located in the County of New York, New York, United States, and each of the parties hereby irrevocably consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such Action and irrevocably
waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such Action in any such court or that any such Action brought in any such court has been brought in an <I>
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
inconvenient forum. Process in any such Action may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each
party agrees that service of process on such party as provided in Section 9.01 shall be deemed effective service of process on such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.10. <I>WAIVER OF JURY TRIAL</I>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY
IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.11. <I>Counterparts; Effectiveness</I>. This Agreement may be signed in any number of counterparts, each of which shall
be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties
hereto. Until and unless each party has received a counterpart hereof signed by each other party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written
agreement or other communication).<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.12. <I>Entire Agreement</I>. This Agreement, the CVR Agreement, the
Tender Agreements and the Confidentiality Agreement constitute the entire agreement between the parties with respect to the subject matter of this Agreement and supersede all prior agreements and understandings, both oral and written, between the
parties with respect to the subject matter of this Agreement.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.13. <I>Severability</I>. If any term,
provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this
Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any
party. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby
be consummated as originally contemplated to the fullest extent possible.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;9.14. <I>Specific Performance.
</I>The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches of
this Agreement or to enforce specifically the performance of the terms and provisions hereof in any <I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
state or United States federal court located in the County of New York, New York, United States, in addition to any other remedy to which they are entitled at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[The remainder of this page has been intentionally left blank; the next page is the signature page.] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the date set forth on the cover page of this Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PROSENSA HOLDING N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PROSENSA HOLDING N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BIOMARIN PHARMACEUTICAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BIOMARIN FALCONS B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Part 1. Pre-Launch Condition </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any other
provision of the Offer, the Offer Commencement Date shall occur if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top">The consultation procedures with the Company&#146;s works council and/or employee representative bodies have resulted in positive advice or neutral advice in respect of the Offer, the Reorganization and the nomination
of the members of the new Boards, the election of whom is contemplated by Section 2.04(a)(ii) (or an irrevocable waiver in writing of its right to render advice with respect to the foregoing), or have otherwise been finalized. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Part 2. Offer Conditions </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of
the Offer, Buyer shall not be required to, and Parent shall not be required to cause Buyer to, accept for payment or pay for any Shares unless, as of immediately prior to the applicable Expiration Time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top">there shall have been validly tendered in accordance with the terms of the Offer, and not withdrawn, a number of Shares (excluding Shares tendered pursuant to guaranteed delivery procedures that have not yet been
delivered in settlement or satisfaction of such guarantee prior to the expiration of the Offer) that, together with the Shares then owned by Parent and/or Buyer, represents at least 80% of the Shares outstanding immediately prior to the Expiration
Time (the &#147;<B>Minimum Condition</B>&#148;); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top">the applicable waiting period under the HSR Act shall have expired or been terminated; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top">no Applicable Law or preliminary or permanent injunction or other order issued by a court of competent jurisdiction restraining, making illegal or otherwise prohibiting consummation of the Offer or the Asset Sale shall
have taken effect and shall still be in effect; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:Times New Roman; font-size:10pt">(i) the representations and warranties of the Company contained in Sections 3.01(a), 3.02 and 3.22 of this Agreement shall be true in all material
respects as of the date of this Agreement and as of the Expiration Time as if made at such time (other than any such representation and warranty that by its terms addresses matters only as of another specified time, which shall be true only as of
such other specified time), (ii)&nbsp;the representations and warranties of the Company contained in Section&nbsp;3.05(a) and the first sentence of Section&nbsp;3.05(b) of this Agreement shall be
</P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
true in all but <I>de minimis</I> respects (relative to the magnitude of the aggregate consideration payable by Parent or Buyer pursuant to Article 2) as of the date of this Agreement and as of
the Expiration Time as if made at such time (other than any such representation and warranty that by its terms addresses matters only as of another specified time, which shall be true only as of such time), (iii)&nbsp;the representations and
warranties of the Company contained in this Agreement that are qualified by &#147;Company Material Adverse Effect&#148; shall be true in all respects as of the date of this Agreement and as of the Expiration Time as if made at such time (other than
any such representation and warranty that by its terms addresses matters only as of another specified time, which shall be true only as of such time), and (iv)&nbsp;all other representations and warranties (disregarding for this clause (iv)&nbsp;any
materiality or Company Material Adverse Effect qualifications contained in such representations and warranties) of the Company contained in this Agreement shall be true at and as of the date of this Agreement and as of the Expiration Time as if made
at such time (other than any such representations and warranty that by its terms addresses matters only as another specified time, which shall be true only as of such time), with only such exceptions in the case of clause (iv)&nbsp;as have not had
and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top">the Company shall have performed or complied with in all material respects its obligations, agreements and covenants under this Agreement prior to the Expiration Time; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top">the Company shall have obtained the Approval of the Boards and the Shareholder Approvals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">G.</TD>
<TD ALIGN="left" VALIGN="top">since the date of this Agreement, a Company Material Adverse Effect has not occurred; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">H.</TD>
<TD ALIGN="left" VALIGN="top">the resignations of the existing members of the Boards as contemplated by Section 2.04(a)(ii) shall have been obtained; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">I.</TD>
<TD ALIGN="left" VALIGN="top">the Company shall have delivered to Parent a certificate signed by a managing director of the Company dated as of the date on which the Offer expires certifying that the Offer Conditions specified in paragraphs (D),
(E)&nbsp;and (F)&nbsp;have been satisfied; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">J.</TD>
<TD ALIGN="left" VALIGN="top">No Anti-Takeover Measure has been implemented by the Company in relation to the Offer or the Tender Agreements; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">K.</TD>
<TD ALIGN="left" VALIGN="top">this Agreement shall not have been terminated in accordance with its terms. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing conditions in Part 2 of Annex I are for the sole benefit of Parent and Buyer and may be asserted by
Parent or Buyer regardless of the circumstances giving rise to any such conditions and may be waived by Parent or Buyer in whole or in part at any time and from time to time in their sole discretion, in each case subject to the terms of the
Agreement. The foregoing conditions shall be in addition to, and not a limitation of, the rights of Parent and Buyer to extend, terminate, amend and/or modify the Offer pursuant to the terms and conditions of the Agreement in accordance with the
Agreement. The failure by Parent or Buyer at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right and each such right shall be deemed an ongoing right which may be asserted at any time and from time to
time. In addition, each of the foregoing conditions is independent of any of the other foregoing conditions; the exclusion of any event from a particular condition does not mean that such event may not be included in another condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[FORM OF CVR AGREEMENT] </B></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
